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Director of Thesis: 
Pre implantation were 
investigated in vitro to determine the influence of 17-B-
estradiol and progesterone upon viability. Stage 
specific mouse embryos (2-cell, 4-cell, and a-cell) were 
cultured for 8 hours in Whitten's Modified Medium 
supplemented with the following compounds: 17-B-
estradiol, tamoxifen, nafoxidine, progesterone, and 
aminoglutethimide. Upon completion of the culturing 
procedure PIEs were observed for embryonic progression. 
Immunocytochemical assay procedures were also performed 
upon the stage specific embryos in an attempt to 
demonstrate the presence of estrogen and progesterone 
receptors within early PIEs. 
Resultant viability data showed that 4-cell and 8-
cell PIEs are estrogen dependent and that endogenous 
estrogen production occurs in these PIE. Estradiol 
supplemented 2-cell PIEs were inhibited in a 
concentration dependent manner. Tamoxifen and nafoxidine 
both were demonstrated to be effective antiestrogenic 
ii 
agents. No influence of progesterone was shown to exist. 
Viability studies demonstrated the lack of endogenous 
steroid production influence in 2-cell and 4-cell PIEs, 
but a dependence upon endogenous ster.oid synthesis was 
shown within a-cell PIEs. Immunocytochemical studies did 
not demonstrate the presence of either estrogen or 
progesterone receptors within 2-cell, 4-cell, or a-cell 
PIEs. However, receptor studies were deemed inconclusive 
due to the unknown influence of the zona pellucida. 
Evidence obtained sup.ports the concept of embryonic 
genome initiation at the 2-cell state and endogenous 
steroid synthesis at the a-cell PIE stage, but this 
initiation was not demonstrated 
or progesterone receptors. 
Accepted by: 
iii 
occur through estrogen 
ACKNOWLEDGMENTS 
I thank Dr. David Magrane, the chairman of my 
graduate committee, for his advice and assistance during 
all stages of this research. 
Dr. Geoffery Gearner's helpful suggestions ·helped 
greatly improve this thesis. 
Dr. David Saxon's 6ptim_ism helped in· the preparation· 
of this thesis. 
James K. Crager provided many hours of labor in the 
gathering of embryos. 
Finally I would like to thank Dr. Alvin Martin and 
Mrs. Sheron Lear who performed the immunocytochemical 
assay for this research and provided inform!ition 
concerning thfs procedure. 
iv 
TABLE OF CONTENTS 
Acceptance Page ••..•• 
Abstract ............ . .. . ..... 
. . . ...... . 
••• . . . . . . . . 
... . . . 
Acknowledgements 
Table of Contents 
List of Tables 
List of Figui:-es • .. ,• ..... . . .. 
CHAPTER 
I. 
II. 
III. 
Introduction •••.•.•..• 
· Isoiation of PIEs ••.•• 
Embryo Development ••.•••. 
Preimplantation culturing .••. 
Embryonic Genome -Initiation 
steroidal Influences .•••. 
Estrogen and Progesterone 
Anti estrogens · 
Steroidogenisis 
Aminoglutethimide ••••.••• 
• • 
... 
•' ... 
Mechanism of Steroid Action Upon a Gene. 
Steroid Receptors • • • • • • •. 
Hypothesis . • • . . • . . • • • . .• 
. . . . . . . . 
...... 
Materials and Methods 
Materials Used 
Estrous Initiation 
Ovulation Initiation 
Insemination .••.. 
Embryo Recoyery 
Viability Studies 
. . . . . . 
. . . . 
... 
.... 
Culture Media • • • • • • .• 
PIE Culturing .......... . 
Treatment Groups ••••.•••• 
Receptor Determinations ••.••..• 
Collection and Preparation 
Immunocytochemical Assay 
•. 
. .... 
.. • ... 
.. 
• • 
. . 
. . 
Results . . . . . . . . . . . . . . . . • ..... . . . . .. 
Viability Data 
Two Cell •. 
Four Cell 
Eight Cell 
. • 
. . 
Receptor Determination Data 
V 
. . . • ... 
.. 
... 
..... . . 
. . . . ... 
i 
ii 
iv 
V 
vii 
ix 
.PAGE 
1 
3 
7 
9 
13 
15 
19 
22 
25 
27 
29 
30 
34 
36 
36 
37 
37 
37 
38 
40 
40 
43 
43 
49 
49 
51 
.54 
54. 
54 
61 
66 
76 
IV. 
v. 
VI. 
Discussion .................... 
Viability Considerations 
Two Cell PIES 
Four Cell PIEs 
Eight Cell PIES 
Receptor Considerations 
Summary . . . . . . . . . . . . . . . . 
.• 
Conclusions . ..... " ......................... . 
Literature Cited . .......................... . 
vi 
79 
79 
80 
82 
85 
87 
88 
92 
95 
LIST OF TABLES 
TABLE 
1. Development of culture media for mouse 
preimplantation embryo culture based on 
PAGE 
Krebs-Ringer bicarbonate media............... 11 
2. Formulation of Whitten's Modified Medium..... 42 
3. Interaction of 17-B-estradiol · on the . 
progression of 2-cell mouse pre1mplantation 
embryos in vitro culture for 8 hours......... 55 
4. Interaction of antiestrogenic compounds on the 
progression of 2-cell mouse preimplantati6n 
embryos in vitro culture for 8 hours ••.. • • . • • • 57 
5. Interaction of progesterone on the progression 
of 2~cell mouse preimplantation embryos in vitro 
culture for 8 hours .......... ·. . . . . . . . . . . . . . . . 58 
6. Interaction of tamoxifen, progesterone and 
nafoxidine while in the presence of a lµg 
concentration of 17-B-estradiol on the 
progression of 2-cell mouse preimplantation 
embrros in vitro culture for 8 hours......... 60 
7. Interaction of aminoglutethimide on the 
progression of 2-cell preimplantation embryos 
in vitro culture for 8 hours . . . . • • • • . .• . . . • • • • 62 
8 •. · interaction of 17-B-estradiol on the 
,progression of 4-cell mouse preimplantation 
embryos in vitro culture for 8 hours •...••• ·•• 64 
9. Interaction of antiestrogenic compounds on the 
progression of 4-cell mouse preimplantation 
embryos in vitro culture for s hours......... 65 
10. Interaction of progesterone on the progression 
of 4-cell mouse preimplantation embryos in vitro 
culture for 8 hours.......................... 67 
vii 
11. Interaction of tamoxifen, progesterone and 
nafoxidine while in the presence of a lµg 
concentration of 17-8-estradiol on the 
progression of 4-cell mouse preimplantation 
embryos in vitro culture for 8 hours......... 68 
·12. Interaction of aminoglutethimide on the 
progression of 4-cell preimplantation 
embryos in vitro culture for 8 hours......... 69 
13. Interaction of 17-B-estradiol on the 
progression of a-cell mouse pre~mplantation 
embryos in vitro culture for 8 hours • • • • • • • • • 7.1 
14. Interaction of antiestrogenic compounds on the 
progression of a-cell mouse preimplantation 
embryos in vitro culture for 8 hours......... 72 
15. Interaction of progest,erone on t;he progression 
of 8-cell' inouse preiniplantation embryos in vitro 
culture for 8 hours . . . . . . . . . . . . . . . . . . . . . . . . . . 7 4 
16. Interaction of tamoxifen, progesterone and 
nafoxidine while in the presence of a lµg 
concentration of 17-8-estradiol on the 
progression of a-cell mouse preimplantation 
embryos in vitro culture for .. a -hours, . . . . . • • • • 7 5 
17. Interaction of aminoglutethimide on the 
progression of a-cell preimplantation 
embryos in vitro culture for 8 hours......... 77 
viii 
LIST OF FIGURES 
FIGURE PAGE 
1. Time intervals and considerations for hormone 
induced superovulation and PIE capture .. ... . . 5 
i x 
CHAPTER I 
INTRODUCTION 
The formation of a viable mammalian organism begins 
at the time of fertilization. The early stages from 
fertiiization through the time of implantation, ·contain 
mysteries that have eluded many researchers concerning 
these preimplantation embryos (PIEs). The unraveling of 
those· mysteries was hindered, however, until.the late 
1950's due to the lack of biotechnical abilities (Slack, 
1983). Initial difficulties in mammalian embryological 
studies centered around the difficulties of 9bserving 
viviparous mammalian embryos. In order to study the 
development.of these embryos researchers first needed to 
develop methods to isolate preimplantation embryos. once 
the-PIEs were isolated, the need to design culture 
techniques necessary-for embryo survival emerged • 
. . 
Problems concerning the isolation and culturing.of 
PIEs involved the development of techniques to improve 
the maximum number of embryos produced by the organism as 
:well.as c9ntrolling the embryos-through in vitro 
culturing, to al-low uniformity in development (Gates, 
19-71) ·• Also·, the methodology of: handling the live 
embryos in a manner-in which was not-detrimental to the 
1 
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embryo had to be addressed (Bedford, 1971). The problems 
in producing acceptable PIE yields were centered on the 
methodology of inducing superovulation (Edwards and_ 
Gates, 1959; Gates, 1971). The techniques of in vitro 
culturing have evolved ~rom a simple media, designed in 
1949 by Hammonds, to the more productive mediums that are 
known today. The evolution o_f a new generation of 
laboratory·equipment, like micropipetors and the newer 
designs of microscopes, since the early beginnings of 
embryo research when a variety of crude micromanipulating 
tools were used, has also assisted in solving the 
problems of culturing and handiing encountered in the 
outset. 
The more recent advances in cellular and molecular 
biological techniques have_ made-it-possible for 
_experimentat~on on small volumes thro~gh methods like 
electrophoresis and radioimmunoassay (RIAs). Such 
<' 
:methodology has'.~llowed re~earchers the ability to 
discover the presence of specific proteins·, the amount of 
RNA synthesis occurring and the utilization of materials 
to produce the protein products (Bolton, et al., 1984; 
Howlett and Bolton, 1985). The information gathered 
using these techniques has given today's researchers a 
·basis for understanding the early developing embryo's 
activities. 
3 
Isolation of PIEs 
To maximize PIE yield in mice, researchers had to 
resolve the problems associated with concentration and 
timing of gonadotropin injections, the strain and age of 
the mice, and the length of the photoperiod. The problem 
of obtaining a large number of viable embryos was solved 
through methods inducing superovulation. Fowler and 
Edwards (1957) induced superovulation in mice following 
intraperitoneal (IP) injection of two gonadotr?pins. 
The· first gonadotropin was pregnant mare's serum 
gonadotropin (PMSG) followed by a second injection 
containing human chorionic gonadotropin (hCG). Since 
that.time, most superovulation techniques utilized by 
' . ' 
researchers'followed the same basic protocol but with 
varying doses of the gonadotropins ranging from 2 to 10 
international units (IU). This technique was commonly 
used since gonadotropin injections induced _superovulation 
(Edwards and Gates, 1959) and mice produced about three 
times more ova than through spontaneous ovulation (Gates, 
1971). 
Through experimentation with varying times between 
injections, it was found that 44 to 48 hours would permit 
an accurate regulation of the ovulation time (Figure 1). 
This control would then allow for the collection of PIEs 
during specific stages of development according to.the 
time elapsed post-hCG injectio~ (Edwards and Gates, 
1959). The time needed to elapse before the development 
of 2-cell PIEs was found to be 45 hours post-hCG 
(Brinster, 1965a), 4-cell PIEs were found to develop 54 
hours·· post-hCG "(Brinster, 1967), and 8-cell PIEs were 
present 64 hours post-hCG i?}je~tion (Warner and 
Tollefson, 1978) (Figure 1). 
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Besides the use of gona_dotropins and _the . timing . 
between the administrations, it was found that the type· 
of mouse strain used was also important. This 
observation was based on the fact that different strains 
of mice produced different numbers of ova when stimulated 
(McLaren, 1967). It was also known that a more vigorous 
reproductive capacity, like that found in outbred mouse 
strains, produced more viable ova than those that are 
less vigorous, like the inbred strains (Gates and Runner, 
1957). Alo~g with this, prepuberal mice (about 3 weeks 
old) were found to produce the highest.yield of ova 
(Gates, 1971). 
Another factor; the photoperiod,· influences the 
yield of PIEs. Whitten and Dagg (1961) determined the 
maximum yield o·f embryos typically involved a light 
period between 12 and 14 hours. _This photoperiod was 
also found to be required to accurately time ovulatio_n 
events (Gates, 1971). · Since lueteinizing hormon~ (LH) is 
Female Virgin Mouse 
I 
I 
5 IU PMSG (2 p.m.) 
I 
I 45 hrs 
5 IU hCG (11 a.m.) 
I 
I 3 hrs 
Endogenous LH Peak Release 
I 9 hrs 
Ovulation . (11 p.m.) 
I 
. I 
. Fertilization 
I 24 hrs 
2-cell PIE (8 a. m.) 
I 
I 9 hrs 
. 4-cell PIE (5 p.m.) 
i 10 hrs 
a-cell PIE (2 a.m.) 
I 
I 9 hrs 
Compaction 
(45 hrs Post-hCG) 
(54 hrs Post-hCG) 
(64 .-hrs Post-hCG) 
Flgure 1, Time intervals and.considerations for hormone 
induced.silperovulation and·PIE. capture. 
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typically released in a surge that correlates with the 
daily light/dark photoperiod. Further research into the 
action of .LH has also shown that the time between the 
peak LH release and ovulation is about 9 hours. 
Therefore, the timing of mature Graafian follicle 
ovulation is.controlled by endogenous LH stimulation 
(Schultz, 1986). 
PMSG is a gonadotropin that contains follicle 
stimulating hormone (FSH) activity. Thus PMSG will 
induce pre-ovulatory maturation of ovar_ian follicles and 
assure the development of mature Graafian follicles 
(Schultz, 1986). The release of LH by mice following· 
treatment with PMSG was found to occur 11 to 16 hours 
after the second midpoint•of the dark period that is 
about 47 to 52 hours post-PMSG injection as diagramed in 
figure 1 (Gates, 1969). . ," · 
The other gonaqotropin_ ~CG is an·ovuiatory·hormone 
that has LH-like actiyity. Ovulation through the use of 
such an exogenous LH occurs 12 hours following the 
addition of the hCG (Edwards and Gates, 1969)°. 
. . . 
6 
Therefore, because the natural release of LH stimulates 
.ovulation 9 hours after its release pe_ak and exogenous LH 
stimulates ovulation 12 hours after its adminis~ration, 
the exogenous LH is administered, three hours prior to the 
expected endogenous LH peak release (Gates, 1971). 
Therefore, the administration of hCG should be performed 
45 hours following PMSG injection to regulate ovulation 
(Figure 1) (Fowler and Edwards, 1957; Ken_dall, 1979). 
Emi,ryo Development 
The formation and development of the mammalian 
embryo from the zygote stage ~o the blastocyst is a 
process unique in comparison to other tissue types. 
Although multiple cleavage .divisions occur from the 
' . 
I 
zygote to the blastocysts, there is no increased mass 
7 
during the entire· process. The initial embryonic 
division usually occurs 24 hours following fertilization. 
sU:bsequent divisions then occur in intervals of about 12 
hours. Until approximately 60 hours post-fertilization, 
when the embryo is at the a-cell stage, the PIE undergoes 
the process of compaction into a spherical shape (Johnson 
and Maro, 1986). 
The process of compaction involves the blastomeres 
flattening against each other and allowing· for the 
maximum amount of contact between cells. The 
establishment of tight junctions, to fix the.blastomere 
positions and prevent movement, and gap junctions, to 
allow for intercellular communications, also occur at 
this time (Magnuson, et al., 1977). The specific 
molecular events involved in this process have been shown 
to depend upon sterol synthesis, the glycosylation of 
_membrane proteins, and the organization of a 
microfilament network (Brachet and Alexadre, 1986). 
Compaction continues until the 32-cell stage when a 
blastocoel first appears (Slack, 1983). 
8 
Compaction has also been found to be a ca2+ dependent 
action (Slack, 1983, Yamamura and Spindle, 1988). As 
compaction proceeds, each blastomere changes from the 
transient polarity seen in 2-cell and 4-cell PIEs 
(Ziomek, 1987) to a radially polarized pattern (Schultz, 
1986). The significance of the embryc;:mic polarity is not 
completely understood but it may function to prevent the 
loss of the paternal genetic information at the time of 
fertilization of the-egg and may play a role in the 
changes within the membrane of the 2-cell and 4-cell PIE 
blastomeres. The permanent polarity that is established 
in the a-cell stage is believed to provide the foundation 
for the development of the two cell lineages leading to 
the trophectoderm and the inner cell mass of the 
blastocyst (Ziomek,. 1987). Evidence ·has also shown that 
the differentiation of these two cell lines can be due to 
the different environmental conditions the blastomeres 
are exposed to according to their orientation within the 
blastocyst (Tarkowski and Wrobleweska, 1967). 
Preimplantation culturing 
The initial problem for embryo development was the 
evolution of a suitable in vitro culture technique 
· {Biggers, et al., 1971). The first report of in vitro 
9 
cultures of mouse embryos was made by Hammond (1949). He 
used a culture medium of physiological saline, 
supplemented with hen egg whites and yolk. Hammond 
stated that the successful culture of mice embryos 
depends upon the age of the embryos. His attempts to 
. . 
culture 2-cell embryos failed, but he successfully 
cultured a-celled PIEs to blastocyst. 
Whitten (1956a) modified Hammonds media by 
substituting Krebs-Ringer bicarbonate solution for the 
saline to control the pH and adding glucose, penicillin 
and streptomycin. Eventually, he stopped using egg yolk. 
Whitten also found that crystalline bovine serum albumin 
{BSA) was a~ excellent substitution for the egg whites. 
. . 
Along with this, he gassed his medium with 5% CO2 in air 
to establish a .pH of 7.4 {Table 1). With.these changes 
Whitten was able to·culture a-celled mouse PIEs to the 
blastocyst stage with an increase in viability over 
Hammonds media. 
Until 1957 no researcher·was able to culture 2-cell 
and 4"'.'celled PIEs (Whitten, 1956a) • ,Whitten changed this 
fact, however, by modifying his own media. He altered 
10 
the Krebs-Ringer bicarbonate solution by repla_cing 
calcium chloride with calcium lactate. With this change 
he was able to culture 2-celled PIEs to the blastocyst 
stage (1957a) (Table 1). 
Efforts to develop an enhanced Whitten's Medium 
followed (Biggers, 1987), and in 1965(b) Brinster studied 
concentration response curves to discover the optimum 
osmolarity required to support embryonic development. 
The investigations resulted _in the addition of sodium 
lactate, the removal of glucose, and the return to the 
original Krebs~Ringer bicarbonate solution containing 
calcium chloride that Whitten himself had changed. 
Brinster (1965c) also studied the role of metabolic 
intermediates of the Embden-Meyerhoff pathway and the 
citric acid cycle. He found that if pyruvate, 
'phosphoenol pyruvate, and ·oxaloacetate w~re substituted 
for ·lactate, 2-celled PIE development could_.be enhanced. 
Brinster (1965b) determined that low concentrations 
of ,pyruvate had a joint eff~ct-with lactate to enhance 
developmental responses (Table 1). This medium proved to 
enhance the rate·of viability in comparison to Whitten's 
original medium.· Therefore, through Brinster's studies 
(1965a, b, and c), the improved type of medium was 
referred to as Brinster's Medium. It was then noted that 
the availability of pyruvate, lactate, and glucose within 
Table 1. Development of culture media for mouse·preimplantation embryo culture 
based on.Krebs-Ringer bicarbonate media. 
Whitten Brinster Whitten BWW Modified 
Whitten 
1956 1957 1963 1965 1971· 1971 1971 1971 
NaCl X ·X X X X X X X 
KCl X X X X X X X X 
KH2P04 X :ic . X X X X X X 
CaC12 X X X X 
MgS04 X X X X X x. X X 
Ca Lactate X X X X 
Na Lactate X X X X X X 
Na Pyi:uvate X X X X X 
NaHC02 X X X X X X X X 
Glucose ·x X X X X X 
BSA X X X X X X X X 
Penicillin X X X X X X X X 
Streptomycin X X X X X X X X 
EDTA X 
.... 
..... 
12 
the media was advantageous to the embryo's development 
(Biggers and Brinster, 1965). This development led to 
the formation of various modifications-of Brinster's 
Medium into newer forms like a modified Brinster's Medium 
(Brinster, 1971), a new. Whitten's Medium (Whitten, 1971)· 
and BWW Medium (Biggers, et al., 1971) (Table 1). 
Another problem, 'besides_ the development of a 
suitable media to culture 2-cell PIEs through blastocyst, 
was that of a 11 2-cell block phenomenon." ·This event was 
characterized by -the inability of 1-cell embryos that 
have completed the first cleavage division in cultu~e, 
producing a 2-cell embryo, to progress to the 4-cell 
stage while remaining in culture (Cole and Paul, 1965). 
one explanation was presented by Whitten and Biggers 
(1968}. They stated that because some mouse strains could 
not be cultured, unless 2-cell PIEs were present at the 
time of recovery, the block was genetically dependent 
upon the strain of mouse used. In 1977, Abramczuk, et 
al., determined that the addition of 
ethylenediaminetetraacetic acid (EDTA) to Whitten's new 
medium enhances the versatility of the culture medium for 
PIE culture and is widely used by many researchers today. 
This alteration of Whitten's new medium in now called 
'Whitten's Modified Medium (Table 1}. 
1.3 
Embryonic Genome Initiation 
The ultimate source of information controlling all 
activities of a cell is the genome.· A study by Howlett 
and Bolton (1985) indicates that the embryonic genome is 
not expressed until late in the 2-cell stage. If this is 
true the control mechanism of early embryogenesis 
involves another factor(s). Recent advanqes ·in molecular 
techniques have aided researchers in understanding-this 
mechanism (Epstein, 1975). 
· In the formation of the mature oocyte (oogenesis), 
the precursor oocytes accumulate macromolecules and 
·increases 350-fold in size (Magnuson and Epstein, 1987). 
The growth phase of the oocyte ends and is marked by the 
termination of RNA synthesis. The mature oocytes that 
are arrested at the second meiotic metaphase (Howlett and 
Bolton, 1985) then contain sufficient RNA concentrations 
to provide for protein synthesis through the_2-cell stage 
. . (Chen, et al., 1980; Schultz, 1986; Magnuson and Epstein,. 
1987). The mouse egg has then inherited mRNA, tRNA, 
rRNA, and ribo·somal proteins from the maternal ·cell line 
to subsist on until the 2-cell stage (Howlett and Bolton, 
1985): The paternal gamete does not donate tangible 
amounts of such products to be used. The first evidence 
of any embryonic transcription has been found at the 
early to mid 2-cell stag~; while no detectable RNA 
14 
synthesis has been measured in the 1-cell stage. 
Therefore, prior to the 2-cell stage, maternal components 
are being utilized and are done so at the 
post-transcriptional level {Howlett and Bolton, 1985). 
Further research into maternal mRNA utilization has 
demonstrated that from fertilization to the 2-cell stage, 
PIEs lose 70% to 90% of the maternal mRNA. At this point 
in development, however, pro_tein synthesis remains 
constant {Brinster, et al., 1976). 
Once the 2-cell stage has been reached, additional 
RNA must be initiated from the embryonic genome and 
continue for the remaining life span of the PIE. This 
information was extracted from experiments performed on 
1-cell, 2-cell, and 4-cell PIEs using transcriptional 
.inhibitors such as a-amanatin {blocks mRNA synthesis by 
binding preferentially to RNA polymerase II) and 
actinomycln_D {binds DNA and.blocks the movement of RNA 
polymerase preventing RNA synthesis (Alberts, et al., 
1989n. When 'the PIEs were cultured· in environments 
containing these compounds, it was seen that only the 
2-cell and 4-cell PIEs demonstrated inhibition of embryo 
development while the 1-cell PIE was not affected 
(Golbus, et al., 1973; Warner·and Versteegh, 1974). PIE 
genome expression must then replace the influence of. the 
maternal mRNA in the synthesis of required protein 
15 
(Howlett and Bolton, 1985). In fact, it has been 
observed that prior to the second cleavage division a six 
to eight fold increase in protein production occurs. This 
action has, therefore, been considered a result of the 
eml:lryonic genome initiation (Schultz, 1986). · 
A primary factor in the onset of genomic 
transcription in mice is the length of time since 
fertilization. This genomic transcription usually 
follows a cAMP-mediated· transition within· the cell from a 
nonpermissive stat~·to a·permissive state· along with-
·othe:r addition.al events during the 1-cell stage that are 
preparatory events. This transition most likely involves 
a .post-translational modification of transcription 
. . 
factors that are then used to begin the transcriptional 
phenomenon in PIEs (Latham, et al., 1992). 
steroidal Influences 
once suitable methods for the cultivation·, 
harvesting, and .culturing of embryos were developed, 
researchers began investigating the post-fertilization 
stages of development. They have produced simple media 
that provide enough elements to allow for the continued 
development and vi-ability ·of PIEs. These in vitro 
methods of embryo maintenance, however, have demonstrated 
a lag time in embryo development behind that of in vivo 
eml:lryos. The lag time has been attributed to the absence 
16 
of developmental influencing factors, present normally in 
the maternal reproductive tract but absent in the media, 
that enhance the early blastomere proliferation 
(Spielmann, et al., 1980). 
Early embryogenesis, beginning with the 2-cell 
stage, is highly dependent on the embryonic genome for 
the initiation of cell proliferation and differentiation 
(Schultz, 1986). Several possible methods controlling 
the genomic activation are possible, ranging from 
post~translational modifications in embryonic 
transcription factors (Latham, et al., 1992) to hormonal 
influences. Of these hormonal· influences, steroids have 
been the most studied factor thought to be involved in 
the developmental regulation. These steroids appear 
necessary for implantation to occur but it is not clear 
whether steroid hormones actually affect the embryos 
directly or whether their action is on the uterus which 
then secretes some substance that can stimulate the 
embryo (Warner and Tollefson, 1978). 
Early research suggested that the ovary was the sole 
source of the steroids, estrogen and progesterone, 
-necessary for the control of preimplantation as well as 
the-implantation of the blastocyst (Dickmann, et al., 
1975). -In 1973, however, research performed by Perry, et 
al., on pig blastocysts contradicted that theory. The 
17 
investigation presented radioimmunoassay (RIA) evidence 
that a pig blastocyst of 14 days post-coitus had 
enzymatic activities that are similar to enzymes used to 
produce the steroids estrone and 17-S~estradiol. Because 
pig implantation occurs_ 18 days post-coitum, this 
evidence was the first to support biological activity in 
steroid synthesis by the mammalian PIE. Succeeding years 
produced more evidence that the PIE has the capability to 
produce steroids. There is even evidence that ~n rats, 
hamsters,-and mice the PIE is an additional source of 
steroid hormones and that they to, like the ovary, 
synthesize steroid hormones (Dickmann and Dey, 1974; 
Dickmann, et al., 1975). Enzymes other than those that 
produce estrogens as.products have also been found to 
exist in-the PIE, to produce progesterone, testosterone, 
and prostaglandins (Shemesh, et al., 1979). 
Confirmation of PIE steroidogenesis was through 
testing for the presence of specific enzymes responsible 
for steroid production. Since 3-S-HSD 
(3-S-hydroxysteroid dehydrogenase) is a key enzyme in the 
metabolism of steroid hormones, its presence.in cells is 
interpreted as strong evidence for steroidogenesis 
(Dickmann, et al., 1975). The test.was a relatively 
simple one in which the PIEs were incubated in a medium 
containing DHA (Dehydroepiandrosterone) a precursor to 
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estrogen. The PIEs were incubated and checked at regular 
intervals for changes in blue formazan granule.deposition 
and the intensities of deposits were scored to provide 
insight into the amount of positive reactivity or enzyme 
activity (Dickmann and Dey, 1974). These studies showed 
that steroidogenesis in rabbits, rats, hamsters, and mice 
begins at,· or a little before, the·morula stage and stops 
at the early postimplantation stages (Dickmann, et al., 
1975). These studies, however, only involved 1-cell to 
2-cell PIEs and PIEs at the 16-cell to 30-cell stage and 
older. Therefore, the-stages of development between the 
·2-cell and 16-cell morula are still unknown in relation 
to the exact moment steroidogenesis begins. 
Other enzymes are also known to be key enzymes for 
the steroidogenesis of specific hormones such as the 
int~rconversion between estrone and estradiol by 
17-B-HSD, but its activity is considered to parallel that 
of 3-B-HSD (Dipkmann, et al., 1975). Based on the 
evidence gathered, it was then postulated that the 
endogenously p·roduced steroid hormones of the PIE are 
critical for the transformation of the morula to 
blastocyst, for implantation, and for the metabolic 
activities within the PIE (Dickmann and Dey, 1974; 
Dickmann, et al., 1975). 
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Estrogen and Progesterone 
Most studies that focus on hormonal regulation of 
the PIE are concerned mainly with either steroid hormone 
influence via exogenous hormones (those originating from 
sources other than the embryo itself such as the ovary, 
oviduct and uterus) (Warner and Tollefson, 1977 and 1978) 
or through endogenous hormones (those that originate 
through embryonic steroidogenesis) (Dickmann, et al.,. 
1976 and 1977; Sengupta, et al., 1977). Both sources 
appear to exist. It.is also known that, for the 
implantation phenomenon to_work, progesterone and 
estrogen are required (Dickmann, et al., 1975). 
Early experimentation using estrogen showed that the 
hormone, when used in high concentrations, caused the 
formation of small cytoplasmic protrusions (blebs) on 
rabbit PIEs (Daniel, 1964). These blebs are structured 
in such a manner that they lack an organized nucleus and 
contain small amounts of chromosomal material. Their 
formation ·is due to the exce$sive subdivisions of the 
PIEs rendering the blastomeres unable· to distribute their 
nuclear material equally. The addition of 17-B-estradiol 
has also been shown to induce fertilized rabbit ova 
cultured in vitro to express cleavage inhibition and 
fragmentation (Kirkpatrick, 1971). 
Viability studies· performed by DeMoss (1991) 
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demonstrated that 17-8-estradiol inhibits 2-cell 
progression at lµg/ml concentration, but had no affect on 
4-cell and a-cell PIEs. Also, through the culturing of 
PIEs in tamoxifen (an estrogen receptor antagonist) and 
estrogen, DeMoss suggested that 4-cell and a-cell PIEs 
produce endogenous estrogen that influence the PIE's 
embryogenesis. He based this conclusion on his 
observations that exogenous estrogen had no-affect on 
protein production and the administration· of an 
antiestrogen like tamoxifen inhibits various types of 
protein produc~ion. His data is further supported by a 
previous study of Warner and Tollefson (1978) tnat 
observed there is no major stimulation or inhibition of 
RNA synthesis in a-cell and blastocyst PIEs cultured in 
the presence of estradiol. Their research did not 
involve the use of an antiestrogeri, and ~ecause their 
evidence did not show mouse PIEs to be hormone sensitive 
target tissues, .they proposed the theory that estrogen 
could be acting through the promotion of membrane changes 
which could affect cleavage and permeability. Data 
showing 17-B-estradiol directly influences the uptake of 
amino acids in the- blastocyst (Smith and Smith, 1971) 
also seemed to support the latter theory .. The evidence 
presented by DeMoss (1_991) supporting a possible 
autocrine or intracrine relationship of endogenous 
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estrogen upon PIE development seems the more justifiable. 
Progesterone has also been reviewed in both Rl'l'A 
synthesis and cleavage aspects. Similar to estrogen it 
was found that progesterone has no noticeable affect upon 
RNA synthesis (Warner and Tollefson, 1978). The area of 
cleavage results, however, have been contradictory. In 
his early studies, Whitten tested the affects of 
progesterone on mouse blastocyst i~ vitro development 
(1965b and 1957b). He was able to demonstrate that low 
concentrations·of progesterone are not _inhibitory upon 
cleavage divisions but it is concentrations of 4µg/ml.and 
above it is. Kirkpatrick (1971) confirmed Whitten's. 
results, but a study performed by Roberlo and Izquierdo 
(1976) failed to show the same effects at a concentration 
of 4µg/ml. In rabbit studies, progesterone 
concentrations equal to and greater than lOµg/ml 
inhibited cleavage up to the blastocyst stage, but the 
PIEs would recover from the cleavage block when 
transferred to a medium lacking progesterone (Daniel. and 
Levy, 1964) • 
Kirkpatrick (1971) suggested that progesterone 
.interferes with the supply of essenti~l amino acids to 
PIEs through the aggregation of_the molecule at the zona 
pellucida ca!-lsing the inhibit.ion· of zona herniation. 
Everi though progesterone has a negative effect upon PIE 
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development in high concentrations, it was shown that low 
concentrations were actually essential to a blastocysts 
development (El-Bana and Daniel, 1972)~ 
Since neither estrogen nor progesterone alone affect RNA 
synthesis in PIEs, tests using the two in combination 
were performed. This was done to see if both steroids 
interact in a synergistic manner. The results showed 
that there·is no major affect of progesterone and 
estrogen together on RNA synthesis in blastocy_sts and 
a-celled PIEs (Warner and Tollefson, 1978). Other 
experiments were done to see if estrogen offered any 
protection from observed progesterone inhibition 
(Whitten, 1957b; Kirkpatrick, 1971). No protection was 
observed. 
Antiestrogens 
Estrogens are hormones known to induce cell 
replication through the stimulatio~ of mitogenic growth 
.. 
factors and/or their respe¢tive receptor synthesis. 
These mitogens may act in an autocrine or paracrine 
manner. Estrogens and antiestrogens may then modulate 
the growth of cells by differentially influencing the_ 
cellular production of stimulatory and/or inhibitory 
growth factors (Jordan and Murphy, 1990). 
Non-steroidal antiestrogens are known to prevent· 
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estrogen from expressing their effects on many target 
tissues (Clark, et al., 1973; Katzenellenbogen, et al., 
1979). Both agonists and antago_nists of estrogen are 
capable of binding to the same receptor site but their 
subtle changes in the receptor protein conformation. 
determines the substrate/receptor complexes distinct 
biological activity (Jordan and Murphy, 1~90). In the 
case of antiestrogens, the antiestrogen/receptor complex 
can bind to the estrogen response elements similarly to 
the estrogen/receptor complexes, but it does not 
stimulate trans~ription. This type of-action exemplifies 
-one of two classes of antiestrogens. The -first is a 
t~iphenylethylene type that.will permit receptor 
dimerization and binding to the response element but 
prevents the response element from functio-ning because of 
a conformational change in the receptor (Jordan and 
Murphy, 1990). The discovery of another high affinity, 
saturable binding site.for the triphenylethylene 
molecules, called an antiestrogen-binding site, has 
received some ·attention but its involvement as a mediator 
of estrogen responsiveness is still in dispute (Fanidi, 
et al., 1989; Sutherland, .et al., 1980). The other types· 
are considered pure antiestrogens that bind to estrogen 
receptors and prevent receptor dimerization and 
subsequent binding.to the DNA (Jordan and Murphy, 1990). 
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Because standard antiestrogens such as tamoxifen and 
nafoxidine prevent the formation of the appropriate 
receptor complex to activate the genome, they are often 
used in cell cultures as control substances to 
demonstrate that a particular event is estrogen regulated 
through the estrogen receptor (Jordan and Murphy, 1990). 
Tamoxifen ([Z]-2-[4-(1,2-Diphenyl-1-butenyl) 
-pheno_xy]-N, N-Dimethylethanamine) is a newer 
non-steroidal molecule that has been suggested to be a 
potent antiestrogen (Patterson, 1981;. Jordan and Murphy, 
1990; DeMoss, 1991). It is not considered a pure 
antiestrogen but it appears to have an appropriate level 
of antiestrogenic activity. It was originally introduced 
in an effort to ease the symptoms of advanced breast 
cancer where it is known to act as a potent antiestrogen 
(Jordan and Murphy, 1990). The use of tamoxifen has 
since sprea~ to other areas of research. 
Tamoxifen was commonly found to inhibit 
estrogen-stimulated growth when in low circulating levels 
by exhibiting target site specific-effects. Tamoxifen•s· 
activity varies, depending upon the cell line it is 
influencing, ranging from fully estrogenic to totally 
antiestrogenic for the induction of various genes 
(Fuller, 1991). This leads to the speculation that the 
antiproliferative actions of tamoxifen could be mediated 
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via mechanisms other than the estrogen receptor (Jordan 
and Murphy, 1990) ·• However, tamoxifen has been shown to 
bind to the estrogen receptor and activate a 
transactivator function (TAF-1) in the NH2-terminal 
domain but it does not activate the TAF-2 in the 
ligand-binding domain like estrogen. Therefore, the 
differences in tissue and gene activity in the presence 
of.tamoxifen may be determined by whether TAF-1·and TAF-2 
or just TAF-1 activity 'is required (Fuller, 1991). 
Nafoxidine (l-[2-[4-(3,4-Dihydro-6-methoxy-2-phenyl 
-1-naphthalenyl)phenoxy]ethyl]pyrrolidine) is another 
estrogen antagonist that competes with estrogen ·for 
specific binding sites on the same receptor. In studies 
utilizing Jµg/ml of nafoxidine in a medium having 
a-celled PIEs, blastocyst formation was inhibited and the 
administration of lµg/ml of 17-B-estradiol did not 
reverse the effect (Roy, et al., 1981). An9ther study of 
nafoxidine and its effects upon blastocysts, demonstrated. 
that 17-B-estradiol reverses the inhibitory effect 
(Sengupta, 1982). Therefore, both tamoxifen and 
nafoxidine may have antiestrogenic properties in PIEs, 
and may_ de:nionstra~e the estrogen requiri3ments of the PIE . 
. ' 
ilteroidogenesis 
Steroid hormones are generally derived from 
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cholesterol through a series of structural modifications. 
The intact steroid nucleus forms are all synthesized• 
through the same initial enzymatic steps. The synthesis 
of these involve cytochrome P-450 enzymes (mixed 
oxygenases that catalyze steroid hydroxylation). 
The first step of steroid biosynthesis is the rate 
limiting step. This step occurs in the mitochondria of a 
cell and involves a cytochrome P-450 side chain cle~vage 
enzyme (20, 22-desmolase) that converts ch.olesterol to 
pregnenolone; Once pregnenolone is produced it is 
modified by dehydrogenases and hydroxylating enzymes in· 
the endoplasmic reticulum and ·mitochondria to form the 
final steroid product to be secreted (Ojeda, 1988; 
Kaplan, 1988). 
The biosynthesis of progesterone, androgens, and 
estrogens all have sim;larities. The primary correlation 
being the initial, rate limiting step. converting 
cholesterol to· A5-pregnenolone· using 20, 22-desmolase 
(20,22-Des). Pregnenolone.can then be converted ·to 
pro.gesterone by "'JB-hydroxys:teroid dehydrogenase ( 3B-HSD) • 
Pregnenolone can also be modified by 17-hydroxylase to 
.form 17a-hydroxypregnenolone. These.can then be 
modified further to result in androstenedione f.ormation •. 
Testosterone can be produced fr9m the androstenedione and 
subsequently be transformed by aromatase (Ojeda, 1988; 
Kaplan, 1988), the terminal enzyme of the cytochrome 
P-450 complex (Graves and Salhonick, 1979), into 
estradiol. Androstenedione.can also be converted by 
aromatase to form estrone which can then be 
irtterconverted to estr~diol by 17B-hydroxysteroid 
dehydrogenase (17B-HSD) (Ojeda, 1988; Kaplan, 1988). 
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As was stated earlier, researchers have been able to 
find weak concentrations·of 17B-HSD in the PIE as early 
as the 2-cell stage and becomes intense at the morula 
stage. Also, 3B-HSD activity is known to begin at the 
2-cell stage and gradually increases-until the morula 
stage then declines slightly.at the blastocyst stage. 
Estrogen and progesterone, however, have not been 
detected to be synthesized within the PIEs (Kendall, 
1979). Researchers have ~ot even been able to detect the 
conversion of pregnenolone to progesterone by RIA 
analysis in mouse embryos prior to implantation (Sherman 
and Atienza, ·1977). Therefore, E!ven though the enzymes 
necessary for steroidogene_sis are present· in mouse PIEs, 
there has not, as of yet, been any concrete evidence that 
the PIEs are actively synthesizing steroid hormones 
(Kendall, 1979). 
Aminoglutethimide 
Research on aminoglutethimide (AG) showed that it 
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was able to inhibit adrenal steroidogenesis in vivo and 
in vitro by reversibly inhibiting their synthesis from 
cholesterol (Kowal, 1969). In tests on adrenal cortex 
cells using O.lmg/ml of AG, no adverse affects were seen 
on cell growth, viability, glucose metabolism, protein, 
RNA, lipid, and cholesterol synthesis (Kowal, 1969). In 
other experiments it was found that AG did not inhibit 
3B-hydroxysteroid dehydrogenase, 17-hydroxylase, 
21-hydroxylase, or 11-hydroxylase which are used to 
convert ~5-pregnenolone to cortisol. However, there. was 
an increase in the levels of lipids and cholesterol. 
-These results suggest that AG blocks the conversion of 
cholesterol to ~5-pregnenolone·, the initial step in 
steroid biosynthesis (Camacho, et al., 1967). 
AG has the ability to inhibit the conversion of 
cholesterol to pregnenolone (Kowal, 1969; Faglia, et al., 
1971) •· The. key site of inhibition by AG is the 
cytochrome P-450 enzyme that is associated with 
cholesterol side chain cleavage (Uzgiris, et al.; 1977). 
AG's main inhibitory effect is on the 20,22-desmolase 
complex activity and the 20-hydroxylation of cholesterol 
side chains (Horky, et al., 1972). It is able to inhibit· 
the cholesterol side chain cleavage by forming a ligand 
with the terminal oxidase cytochrome P-450 (Graves and 
Salhonick, 1979j. -This inhibition has been demonstrated 
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with in vitro and in vivo studies in both animals and 
humans (Faglia, et al., 1971). It has also been shown 
that AG can inhibit the conversion of androstenedione to 
estrone through the aromatase enzyme (Graves and 
Salhonick, 1979). 
_Mechanism of steroid Action Upon a Gene 
Generally speaking, steroid hormones enter the 
target cells, interact with a receptor, and ultimately 
activate or deactivate a portion of the genome. Free, 
disassociated steroid molecules are characteristically 
small (mw = 300) hydrophobic molecules that have the 
ability to cross the plasma membrane by simple diffusion. 
At this point. a hormone_ can bind to a complementary 
receptor protein in a tight but reversible manner 
(Alberts, et al., 1989). 
Recep~or/hormone complexes then bind the DNA often 
times in the form of dimers (heterodimers and homodimers) 
at a hormone enhancer site (Fuller, 1991)". The ·location 
of binding can.vary from being adjacent to the target 
gene to being located great distances in either the 3' or 
. . 
5' end (Ptashne, 1986). The complex, once associated 
with the enhancer site, is able to reguiate 
transcriptional initiation through a mechanism that is, 
to date, still not completely understood (O'Malley and 
Tsai, 1992; Ptashne, 1986). What is understood is that 
many times, hormone/receptor complexes bound to the DNA 
at different. !:lites can· interact in a synergistic manner 
•-.o.."!,:•·•~ !.-::' '7::, · 7_ • • 
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to intensify the amount of control (Hecht, et al., 1988). 
The hormone/receptor complex may also bind to the 
specific DNA promoter site and result in a conformational 
change of the chromatin structure resulting in the· 
displacement of a nucleosomal structure. The nucleosomal 
structure, when present, masks other transcriptional 
binding sites that need to be bound for promotion of. a 
gene. If the.nucleosome is displaced, then the other 
transcriptional binding sites are opened up, allowing for 
the corresponding transcriptional factors to bind and 
control a gene• (Truss, et al., 1992). 
Steroid Receptors 
For any hormone·to act upon~ cell it must do so 
through a receptor. Most steroid receptors are believed. 
to be predominantly nuclear in location (Fuller, 1991). 
These receptors are protein structures that are quite 
specific for the particular ster?id molecule they can 
bind. They do, however, exemplify similarity and 
conservation of both function and structure: Structural 
similarities are visible in two of the three main domains 
composing the receptors, the DNA binding domain and the 
COCH-terminal ligand-binding domain. 
The DNA binding domain is the most conserved region 
of the two. In fact, of the 66-68 amino acids present, 
18 are invariant across all animal species. The 
importance of this centrally located domain belongs to a 
zinc finger _structure that is involved in the attachment 
of the receptor to the DNA at a specific enhancer site or 
response element (Fuller, 1991). Zinc fingers are 
sequenc~·specific when binding DNA and are actually 
composed of tw'o ·. fingers_, an· N-terminal _ and 
c~terminal finger. Together, they determine the target· 
site specificity (Schule, et al., 1988) •· 
The second most highly conserved domain, the COCH-
terminal ligand-binding domain is responsible for 
complexing.with the steroid molecule. Once the 
steroid/receptor complex is formed, a _configurational 
change of the receptor occurs exposing.the third domain, 
the poorly conserved ~H2-terminal domain. This final 
domain has the primary function of transactivation and 
has been termed the activating region (Fuller, 1991). _ 
. ' . 
The activating region is regarded to interact with 
.promoters and cell specific transcription factors to 
enhance transcription (Meyer, e_t al. , 19·99) • 
Research considering steroid receptors has only just 
recently increased in activity. In fact, it was not 
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until 1983 that steroid receptors were shown to bind to 
the DNA directly. Advancement was made possible mainly 
due to the development of recombinant DNA technology 
allowing for larger concentrations and specificity in 
forms of receptors to be readily synthesized (Alberts, et 
al., 1989). Once the techniques for receptor production 
were devised, it was shown that steroid receptors fall 
into four classes according to sequence. One class is 
called the glucocorticoid response element (GRE). This 
group includes receptors for androgens, 
mineralocorticoids, and progesterone. The other classes 
are the estrogen response elements (ERE), thyroid 
response elements (TRE), and an orphan receptor class 
(named so due to a functional similarity with.other 
receptors but there is no.known ligand to activate them) 
(Fuller, 1991) • 
Other hormone receptors, besides-steroid forms, have 
been found to be produced by preimplantation embryos 
between the 4-cell and 8-c_ell stages. One example is the 
epidermal growth factor receptor (EGF-R). Epidermal 
growth factor (EGF) is also a product of early 
preimplantation stages of mouse embryos. Besides embryo 
derived EGF-Rs, the epithelial cells and stromal cells of" 
the maternal uterus also express EGF-Rs. The embryo 
derived EGF most probably has both an autocrine function 
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as well as a paracrine activity. This information 
suggests that embryos norma.lly condition their. own 
environment with hormones to prepare the uterus for 
implantation while stimulating themselves (Wiley, et al., 
·1992), Therefore, from this information it is logical to 
question if PIEs use other hormones, such as estrogens 
and/or progesterone, in a similar ·manner. 
It. has also been found that receptors for estrogens 
can be isolated from the cytoplasm of rabbit blastocysts 
(Bhatt and Bullock, 1974). A system has recently been_ 
developed that is commonly used to detect- the presence of 
-these receptors (Abbott, 1990 and 1991). It is an 
immunocytochemical assay system that utilizes a sensitive 
peroxidase-anti-peroxidase technique allowing for the 
visualization of either the estrogen or progesterone 
receptors within a specimen. A monoclonal antibody is 
directed specifically against the receptor_ o_f either the 
estrogen or progesterone substrate depending on the 
desired receptor to be studied. This test is not similar 
to methods-such as radio immunoassays, which are based on 
the binding of a substrate to the receptors binding site 
thus labeling it, instead.it is based on direct antigenic 
recognition of the receptor. The technique has 
successfully been used to determine the presence of 
estrogen receptors.in tissues of rabbit uterus, oviduct, 
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corpus luteum, mammary gland, pituitary and liver, 
cultured breast cancer cells, human breast cancer cells, 
and human endometrium protein. The primary use today 
involves the measurement of estrogen and progesterone 
receptors within tumor tissues such as breast cancer 
tissue to aid in the determination if the tumor will 
respond to some type of hormone treatment. Possible 
limitations of the assay technique is dependent upon. 
possible cross-reactivity of the rat·IgG with the tissue 
to be studied. There has been no indication of possible 
reactivity with mouse tissue to date. Another limitation 
to this procedure is its inability to demonstrate 
receptor presence in concentrations less than 10 
femtomoles/mg of protein. 
Hypothesis 
This s~udy will attempt.to determine the influence 
. . 
of exogenously administered 17-B-estradiol and 
progesterone on in vitro cultured preimplantation 
. . 
embryos. Specifica~ly this research hypothesizes that 
17-B-estradiol and progesterone influence PIE development 
by binding to their respective receptors within 2-cell, 
4-cell, and a-cell preimplantation embryos. This study 
will also attempt to verify the· antiestrogenic properties 
of tamoxifen and nafoxidine, and determine if there is 
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steroid synthesis by the preimplantation embryos that 
influence the embryo's development through the use of 
aminoglutethimide, a steroid synthesis blocker. Analysis 
of 17-B-estradiol and progesterone influence, tamoxifen 
and nafoxidine antiestrogenic properties, and steroid 
synthesis blockage upon 2-cell, 4-cell, and s·-cell 
preimplantation embryos will be determined through 
comparative viability studies. Analysis of· estrogen and 
progesterone receptor presence in concentrations greater· 
than 10 femtomoles/mg of protein will be determined. 
through the u~e of an immunocytochemical assay of 2-cell,. 
4-cell, and 8-cell preimplantation embryos. 
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CHAPTER rr 
METHODS AND MATERrALS 
Materials Used 
Preimplantation embryos (PIEs) were recovered from 
hormone-stimulated female mice of the ICR crossbred 
strain (Harlan Sprague Dawley, Inc.) that were 5-12 _weeks· 
of age. All mice were maintained under·a constant 
photoperiod of 14 hours light and 10 hours dark. The 
dark period occurred between 9:00 PM and 7:00 AM. Mice· 
were feed Purina Mouse Chow (Ralston Purina Company) and 
water ad libitum. A maximum of 4 mice were placed in a 
cage and kept in the Lappin Hall Animal Facility. 
Estrous cycle was initiated by the injection of Pregnant 
Mares' Serum Gonadotropin (PMSG, Sigma Chemical Co.) and 
superovulation was induce~ through an injection of huma~ 
chorionic · gonadotropi_n · (hCG, Sigma Chemical Co.) • 
Recovery and culture.of PIEs were performed in the 
presence of Whitten's Modified Medium. Incubation 
occurred in an incubator chamber allowing an environm.ent 
. of 37°C in humid atmosphere of 5% CO2 in air. All visual 
observations were under a stand_ard dissecting ll!icroscope, 
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Estrous Initiation 
The initiation of the estrous cycle was achieved 
through the use of a gonadotropin (Fowler and Edwards, 
1957; Gates and Dronkert, 1965). Pregnant Mare's Serum 
Gonadotropin (PMSG) was delivered in doses of 5 
international units ( 5 IU) within a 0.05-cc volume via 
intraperitoneal injection (Warner and Tollefson, 1978; 
DeMoss, 1991) using a 1-cc syringe with a 25 2/3-gauge 
needle. The PMSG injections were performed at 2:00 p.m. 
for each group of experimental animals in order to 
synchronize all mice estrous cycles to coordinate the 
subsequent hCG injections at a time when the highest 
number of ova have matured. 
Ovulation Initiation 
Human chorionic gonadotropin (hCG) was administered 
intraperitoneally through injections of 5 IU (Warner and 
Tollefson, 1978; DeMoss, 1991), within a 0.05-cc volume 
using a 1-cc syringe with a 26 2/3-gauge needle. 
Injection of hCG occurred 45 hours post- PMSG injection at 
11:00 a.m .. 
Insemination 
Immediately following hCG injection two females were 
placed in a breeding cage along with a proven fertile 
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male. At 14 and 21 hours post-hCG injection each female 
was inspected for a vaginal plug (sperm plug) .to verify 
successful copulation (Poueymirou and Schultz, 1987). 
Two inspection times were chosen in order to procure 
verification of all copulatory events and not misjudge 
any positive activity due to· the reabsorption or loss of 
the sperm-plug. Negative copulatory females were 
observed for 10-21 days to determine that·no mating had 
occurred and were again subjected to the hormonal 
stimulation via PMSG and hCG and placed with males.-
Females with sperm plugs were held till the desired PIE 
-recovery time was reached and embryo recovery ensued. 
Eml>ryo recovery 
Preimplantation embryo recovery was performed 45, 
54, and 62 hours post-hCG injection to retrieve 2-cell, 
4-cel-l, and. a-cell embryos, respectively (~rinster, 19 65 
and 1967; Warner and Tollefson, 1978). Females were 
sacrificed via cervical dislocation and the skin-with 
hair was removed from the ventral abdominal wall prior to. 
oviduct excision to prevent contamination by hair. An 
incision was made mid-ventrally, lengthwise running from 
the rib cage down to the external genitalia. Also, two 
lateral incisions along the rib cage were made and the 
skin was retracted.using forceps to expose the viscera. 
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The ventral abdominal wall was removed by making a 
lateral incision just anterior to the hind legs and two 
additional incisions running from the lateral cut to the 
rib cage along the lateral abdominal wall were made. The 
muscle mass was removed and placed between the forelegs. 
Once the viscera was exposed the digestive tract and any 
fat deposits were moved from one side to the other to 
allow access to the uterine.horns, ovaries, and oviducts. 
The removal of the oviducts was executed by cutting 
the uterine horns anteriorly to the uterine body using 
microdissection scissors. The uterine horn and oviduct 
were lifted up from the abdominal cavity by. using 
watchmaker's forceps and the connective tissue was 
removed. The oviduct was then separated from the ovary 
by cutting the bursa near the ovary (Schneider, 1970). 
The resultant piece of uterine horn and oviduct were 
placed in <1, deep-welled glass dish containing a small 
amount of clean Whitten's Modified Medium (Poueymirou, et 
al., 1989; DeMoss, 1991). 
Using a standard dissecting micz:oscope, each oviduct 
was removed from the·ut~rus following the removal of 
connective tissue on the oviduct near the uterotuberal 
junction. The junction was then severed (Weldon, .1971) 
and each oviduct was moved to a clean pool of Whitten's 
Modified Medium. A 30-gauge needle, attached to a 1-cc 
40 
syringe filled with Whitten's Modified Medium, ·was 
inserted into the oviduct. The oviduct was then flushed 
gently in order to force PIEs out of the oviduct and into 
the glass dish. Immediately following the flush, all PIEs 
were washed twice in clean pools of culture media within 
sterile watch glasses. The transfers were conducted 
through the use of a micropipetor (Rainin, P-20 Pipetman) 
set at 2µ1 units, with a gel loading tip. ·Transfers were 
performed to dilute out and_ minimize any.concentrations 
of hormones and/or·other materials that may have been 
present in the oviduct at the time of flushing. 
Transfers also served to remove any cellular debris (eq. 
red blood cells) and lipid droplets (Brinster, 1967). 
After the second wash, the PIEs were placed in culture 
dishes containing fresh Whitten's Modified Medium, and 
placed in an 'incubator. 
vlability studies 
Culture media: Whitten's Modified Medium was used 
in the recovery and culturing processes of mouse PIEs. 
This medium was-chosen due to its proven ability to 
supply proper environmental and nutritional·needs· of 
murine PIEs in order to facilitate the development to the 
succeeding stages of embryonic PIE development through 
compaction (Abramczuk, et al.; 1977; DeMoss, 1991). Each 
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week fresh Whitten's Modified Medium was prepared in 
100ml volumes to insure the least possible contamination, 
degradation of components, and unnecessary waste of 
media. 
Whitten's Modified Medium was prepared in accordance 
to the established protocol of Whitten (1971) and DeMoss 
(1991). The weights and volumes of all components are 
listed in Table 2. Sodium chloride, potassium chloride, 
potassium monophosphate, magnesium sulfate, sodium 
bicarbonate,-sodium pyruvate, calcium lactate, glucose, K 
penicillin G, and streptomycin sulfate were dissolved in 
100ml of distilled water. Sodium lactate 60% and 
ethylenediaminetetraacetic acid (EDTA) were added along 
with 1% (w/v) phenol red, which was used as a crude pH 
indicator.· Crystalline bovine serum albumin was added 
and gently dissolved into the solution, by light to 
moderate agitation to prevent frothing, following all 
other additions. The medium was gassed with carbon 
dioxide until a pH of 6.8 to 7.2 was reached (Brinster, 
1965). The medium was filtered usin~ a disposable filter 
apparatus (Nalge 120 Nalgene, Inc.) with a 0.2 micron 
filter. The medium was stored in a covered container and 
refrigerated at- 4°C until used. Prior to the use of media 
for culture, portions of medium were transferred to an 
incubation chamber and kept at 37°C in a humid 
Table 2. Formulation of Whitten's Modified Medium (Whitten, :1971) 
Ca 
K 
Component 
NaCl 
KCl 
KH2P04 
MgS04 * 7Hz0 
NaHC03 
Na Pyruvate 
Lactate * 5H20 
Glucose 
Penicillin G 
Streptomycin S04 
Distilled H20 . 
6~% Sodium Lactate 
1% Phenol Red 
. 10mM EDTA 
Bovine Serum Albumin 
Concentration/100ml 
514.00 mg 
36.00 mg 
16.00 mg 
29.00 mg 
190.00 mg 
3.50 mg 
53.00 mg 
100·.00 mg 
s.oo mg 
5.00 mg 
100.00 ml 
0.37 ml 
0.10 ml 
1.00 ml 
300.00 mg 
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environment containing 5% CO2 to prevent any shock'to PIEs 
from the radical change in the environmental temperature 
and atmosphere. 
PXE culturing: At the time of PIE placement into 
media for cu_l ture, 1ml of the medium was placed into. the 
center well of an 60 x 15mm style organ tissue culture 
dish (Bioquest Falcon Plastics Division). Protocol 
required 3 embryonic stages of PIE development: 1) 
2-cell stage (45 hours post-hCG) 2) 4-cel·l st,age (54 
hours post-hCG) 3) a-cell stage (64 hours post-hCG). 
Groups of ten embryos were used per· culture dish during 
·incubations. PIEs were cultured for 8 and 10 hours in 
each of the treatment groups.· Each of the culture groups 
were done in two replicas, for a total of 20 embryos per 
treatment group. 
Treatment groups: All solutions were added to the 
1ml !=)'f'Whitten's.Modified Medium and 10 PIEs. 
Group .x: Eth~nol-saline solution (50µ1). The 
control solution was prepared through the addition of 
:20µ1 of ·absoiute· ethanol to 1ml of sterile saline 
. ' 
solution ( o; 9% ·NaCl) tcr make a 1. 4 x 10·2mM solution of 
ethanol. 
Group XX: 17-S-estradiol (lµg/50µ1). The 
preparation of the .stock 17-S-estradiol solution 
(1mg/1ml) was ·performed by dissolving 10mg of 
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17-B-estradiol into 10ml of absolute ethanol to make a 
3.6mM concentration of 17-B-estradiol (Roy, et al.,1981). 
The 1µ.g/50µ.l solution was made by diluting 20µ1 of the 
stock solution with sterile saline solution to a fin.al 
volume of 1ml. The resulting solution has a 
concentration of 7. 3 x 10·2mM 17-B-estradiol and 4. 2 x 
10-1mM ethanol (Roy et al., 1982). This concentration was 
chosen as a result of published reports indicating 
treatments of PIEs with this concentration have no 
deleterious effects upon development. (Roy, et al., 1982; 
Warner and Tollefson, 1977). A 50µ.l aliquot of the 
20µ.l/~ml solution was added to the culture dishes for 
this treatment g~oup to give a· total addition of 1µ.g of 
17..,;B-'estradiol (3.4 x 10-2mM) a:nd 1.4 x 10·2mM ethanol (Roy 
et al_., 1982). 
Group III: 17-B-estradiol (0.·5µ.g/50µ1). Ten 
' . ' I 
microliter~ of the stock solution was diluted with 
sterile saline solution to a-final volume of 1ml. A 50µ.l 
al_iquot of the 10µ.l/lml solution was added to the culture 
dishes for this treatment group to give a total addition 
to 0.5µ.g of 17-B-estradiol. 
Group IV: 17-B-estradiol (0.25µ.g/50µ.l). Five 
microliters of the stock solution was diluted with 
sterile saline solution .to a final volume of 1ml. The 
resulting solution was then a 5µ.1/lml concentration of 
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17-B-estradiol. A 50µ1 aliquot of this solution was then 
added to the culture dishes for this treatment group to 
give a total of 0.25µg· of_ 17-B-estradiol. 
Group V: Tamoxifen (Jµg/50µ1). The tamoxifen stock 
solution was prepared by dissolving 1mg of tamoxifen in 
50µ1 of absolute ethanol and then diluted to 1ml using 
sterile saline. The procedure resulted in a lµg/1µ1 
solution of tamoxifen. For this treatment group Jµl of 
the.stock lµg/1µ1 solution of tamoxifen was added to the 
1ml of culture medium and 50µ1 of the ethanol-saline. 
solution from.Group I was also added. 
Group VI: Tamoxifen (2µg/50µ1). Medium plus 2µ1 of 
the stock tamoxifen solution. along with 50µ1 of the 
ethanol-saline solution from Group I. 
Group VII: Tamoxifen (lµg/50µ1). Medium plus lµl 
of the stock tamoxifen solution along wi_th 50µ1 of the 
ethanol-saline solution of Group I. 
Group VJ:II; Nafoxidine (Jµg/50µ1). The nafoxidine . 
solution was prepared by dissolving 1mg of nafoxidine.in 
50µ1 of absolute ethanol and then diluting to 1ml using 
sterile saline. · A Jµl aliquot of the solution was added 
directly to the medium along with 50µ1 of ethanol-saline 
solution of Group I. 
Group IX: Progesterone (lµg/50µ1). The 
progesterone stock solution (1mg/1ml) was prepared by 
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dissolving 10mg of progesterone into 10ml of absolute 
ethanol. To make a lµg/50µ1 solution, 20µ1 of the stock 
solution was diluted with sterile saline solution to a 
final volume of 1ml. A 50µ1 aliquot of the lµg/50µ1 
stock solution was then added to the medium. 
Group x: Progesterone (0.5µg/50µ1). A 10µ1 aliquot 
of the stock progesterone solution (1mg/1ml) was diluted 
to a final volume of 1ml with sterile saline solution. 
Fifty microliters of the resulting 10µ1/lml solution was 
then added to the medium. 
Group XI: Progesterone (0.25µg/50µl). A 500µ1 
sample of the progesterone solution from Group X 
(10µ1/ml) was diluted to 1ml with sterile saline to 
produce a 0.25µg/50µ1 solution of progesterone, of which 
50µ1 was added to the medium. 
Group XII: Tamoxifen (3µg) plus 17-B-estradiol 
(lµg/50µ1). Three microliters of the tamoxifen stock 
solution was added to the medium and incubated for 15 
minutes. Following the given time period 50µ1 of the 
20µ1-/lml solution of 17-B-estradiol was introduced into 
the medium. The delayed administration of 17-B-estradiol 
. was done to permit tamoxifen sufficiept time to bind the 
estrogen receptors·, if present •. 
Group XIII: Tamoxifen · (•2µg) plus 17-B-estradiol 
(lµg/50µ1), Two microliters of the tamoxifen stock 
solution was added to the medium and cultured similarly 
to Group XII. 
Group XIV: Tamoxifen (lµg) plus ·17~B-estradiol 
(lµg/50µ1). A lµl aliquot of the tamoxifen stock 
solution was added to the medium and cultured similarly 
to Group XII. 
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Group xv: Nafoxidine (3µg) plus 17-B-estradiol 
(lµg/50µ1)" •. A 3µ1 aliqu·ot of nafoxidine stock solution 
was added to the medium and incubated for 15 minutes. 
Following the given time period 50µ1 of the 20µ1/lml 17-
B-estradiol solution was introduced to the medium. The 
delayed administration was done to permit nafoxidine 
sufficient time to bind the estrogen receptors, if 
present. 
Group XVI: Progesterone (lµg/25µ1) plus 17-B-
estradiol (lµg/25µ1). A 40µ1 volume of the 1mg/1ml stock 
progesterone solution was diluted to ·a final volume of 
.lml with sterile saline. Thelµc;J/25µ1 17-B-estradiol 
solution was prepare_d similarly to the lµg/25µ1 
progesterone solution.. . Both s~lut:ions. were added to the 
medium in 25µ1 aliquots at about the same time. 
Group XVI:i:: Methanol-saline solution (50µ1). The 
control solution was prepared through the addition of 
20µ1 of methanol to 5ml of sterile saline solution. A 
50µ1 volume of the stock solution was the added to the 
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medium. 
Group ~III: Aminoglutethimide (l0µg/50µ1). The 
preparation of the stock aminoglutethimide solution 
(1mg/5ml) was performed by dissolving 5mg of 
aminoglutethimide in 100µ1 of methanol.. The solution was 
then stirred for about 2 hours. Fifty microliters of the 
solution was·then added to the medium. 
Group XIX: Aminoglutethimide (lµg/50µ1). 100µ1 of 
stock aminoglutethimide solution (1mg/5ml) was diluted to 
a final volume of 1ml with sterile saline solution .. 
Fifty microliters of th,e resulting lµg/50µ1 solution was 
·then added·to the medium. 
Group X~: Aminoglutethimide (0.lµg/50µ1). 100µ1 of 
.. 
the lµg/50µ1 aminoglutethimide solution was diluted to a 
final _volume o_f 1ml with sterile saline solution. Fifty 
of the resulting O.lµg/SOµl·~otution 'was theri added to 
the medium •. 
The culture experiments using 2-cell, 4-cel·l and 8-
cell PIEs were conducted in collections of 10 embryos 
with 2 replicas for each treatment group. Twenty PIEs 
were cultured per_treatment group for each developmental 
' 
stage. Immediately following embryo transfer to the 
medium within the culture dish and addition of steroids, 
steroid antagonists, or aminoglutethimide, the PIEs were 
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incubated for 8 hours at 37°C in an atmosphere of 5% CO2 
in air. The PIEs were then examined for viability 
following the 8 hour incubation. Viability was based on 
the progression of 2-cell, 4-cell, and a-cell PIEs to 4-
cell, 8-cell, and morula stages respectively. PIEs not 
progressing or failing to advance during the given 
incubation period were considered inhibited in their 
development or inviable. 
Statistical. significance between PIE treatment 
groups was determined thro.ugh the use of the standard 
normal z-statistic that was used at p < o.05. 
Receptor determination 
Collection and Preparation of specimens: Upon 
collection of PIEs (in the same manner as stated 
previously) at the 2-cell, 4-cell, or a-cell stage, the 
embryos we~e temporarily placed in Whitten's Modified 
Medium to allow for pooling of all embryos gathered 
without.any detrimental effects upon theni. Once gathered 
and washed twice with new media, one third of the 
collected embryos were picked up in a small volume of 
media (4µ1) using .a.microliter pipetor (Rainin, P-20 
Pipetman). Cells and media were then gently expelled 
onto the surface of a microscope slide pre-treated with a 
tissue adhesive (Fisher Biotech ProbeOn Plus microscope 
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slides), the three stages tested (2-cell, 4-cell and a-
cell PIEs) were placed on separate sections of the slide 
to aid in location of different stages as desired and 
. . 
spread gently over a small area, to allow for dispersion 
of PIEs in a small area. The slide was then allowed to 
air dry just until the edges began to dry, to give the 
PIEs sufficient time to bind to the slide surface. At 
this point the slide was placed into a microscope slide 
transfer container filled w_ith 95% ethyl· alcohol (95ml 
ethanol plus 5ml H20) to fix the PIEs. The remaining 
embryos not already placed onto a slide were then divided. 
in half and placed on individual slides in the same 
manner as above to give a total of three slides all 
·containing an equal number of PIEs for that embryonic 
stage of development. One served as a negative control, 
one for the estrogen receptor determination_, and one for 
the progesterone receptor determination. All slides were 
kept in the 95%.ethyl alcohol solution at all times at 
room temperature. At no time were the slides allowed to 
dry completely, to prevent desiccation of the PIEs and 
any possible loss of receptors. Slides were then 
transported to the Special Procedure Laboratory at· the 
University of Louisville Medical and Dental Research 
Building ~ithin 24 hours, where the immunocytochemical 
staining procedure was performed. Staining was done 
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within 24 hours of PIE collection to prevent any possible 
loss of receptors over an extended time period. Only one 
slide was used as a negative control since both the ER-
ICA and PgR-ICA systems used the same methods to produce 
a negative control slide. 
Fifteen PIES in the 2-cell stage of development were 
collected and 5 PIEs per slide. PIEs in the 4-cell stage 
of development were collected and 90 PIEs were used, 30-
PIEs per slide prepared. PIEs in the a-cell stage of 
development were collected and 18 PIEs were used, 6 PIEs 
per slide prepared. 
Immunocytochemical Assay: The staining procedure 
began with the placement of slides into a PBS solution 
(0.0lM phosphate buffered saline, pH 7.2 to 7.4). The 
slides were removed, a blocking reagent was added to the 
slide dropwise to pre:vent any nonspecific binding by the 
• t ' . ' 
subsequent antibodies, and the slides were incubated for 
15 minutes at.room·temperature in a humidified chamber. 
Excess reagent was removed and the primary antibody-of 
the estrogen receptor was added to· one oCtJ:ie specimens, 
,. . . 
the primary antibody of the progesterone receptor was 
. added to another specimen, and the control antibody was 
added to the third specimen. The slides were ~ncubated 
for 30 minutes in a humidified chamber at room 
temperature. The slides were then placed in two 
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successive PBS baths for 5 minutes. Excess PBS was 
removed and the bridging antibody was added to all slides 
and incubated for 30 minutes in a humidified chamber at 
.room temperature. Two successive baths followed using 
PBS for 5 minutes each.time. A peroxidase-anti-
peroxidase (PAP) complex was added to all slides and 
incubated for 30 minutes in~ humidified chamber .at room 
temperature. Two more successive PBS baths were 
performed for 5 minutes each. Excess PBS was _removed and 
the color development procedure began. 
Color development involved the immediate addition of 
the chromogen substrate solution to each slide following 
'the last PBS bath. The slides were incubated in the 
solution for 6 minutes. Afterwards, the excess solution 
was drained and the slides -were gently ri~sed with 
distilled water for 5 minutes. 
Counterstaining was performed using methyl green. 
During this procequre the slides were placed in the 
methyl green solution for ·_5 minutes then removed and 
rinsed with gently running tap water an additional 5 
minutes. 
The slides were then placed in a 95% ethanol 
solution for about 2 minutes, to begin the mounting 
procedure,-then repeated using fresh solution. The 
slides were transferred to absolute ethanol for about 2 
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minutes and repeated with fresh ethanol, Once removed 
from the ethanol solution and placed into two successive, 
fresh xylene solutions for 2 minutes each. Finally a 
coverslip was added to each slide with permount. 
Positive control slides were also done at the same 
time as·the above to insure the reagents and methodology 
used were suitable and in working·condition. These 
slides were prepared using tissue from· a tissue sample 
containing breast tumor cells known to positi~ely stain 
using the procedure. 
Determination for·the presence of estrogen and/or 
·progesterone receptors was done through the use of a 
standard light microscope. Indication of a reddish-brown 
stained nucleus within the PIEs, more than that shown by. 
the negative control slide, should suggest receptor 
presence. The lack of a reddish-brown stained nucleus 
but instead a green stained nucleus, due to.methyl green 
counterstaining, demonstrates the receptors are not 
present or are in concentrations less· than 1x10-14M/mg of 
protein. This test is not quantitative but is 
qualitative for receptor pre:;;ence and, therefore, 
suggests only the presence and not specific 
concentrations of the receptors if greater than 
1x10-14M/mg of protein. 
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CHAPTER III 
RESULTS 
Viability.Data 
Two Cell PIEs: Following ans hour incubation 
period, preimplantation embryos for individual treatment 
groups were observed·to determine if cleavage or cell 
division had occurred during incubation. Collected data 
for the influence of 17-S-_estradiol at varying 
concentrations on 2-cell PIE progression are presented in 
Table 3. The control treatment group, Group I (Ethanol-
saline), had an 80% progression to the ensuing 4-cell 
stage. Therefore, addition of 50µ1 of the ethanol-saline 
solution to the Whitten's Modified Medium allowed for the 
progression of a suitable number of embryos and provided 
confirmation for the use of 'ethanol-saline solution 
addition as an experimental control in viability 
comparisons. 
Treatment Group II, PIES incubated in the presence 
of lµg 17-S-estradiol, exhibited a progres~ion of 4 PIEs 
out of 20 to the 4-cell stage. This reduction in 
progressi,on as compared to tJ:ie experimental control was 
found to be significant-at p<0,'05. Treatment Group III 
·' and· IV, 0.5µg and 0.25µg of 17;_8-estradiol, permitted 11 
Table 3. Interaction of 17-B-es.tradiol on the progression of 2-cell mouse 
preimplantatiori embryos in vitro culture for 8 hours. 
Group 
II 
III 
IV 
I 
Concentration of. 
Drug/Vehicle per ml 
17-B-Estradiol 
(lµg) 
17-B-Estradiol 
co·. 5µg) 
17-B-Estradiol 
(0.25µg) 
Ethanol-Saline 
Control (50µ1) 
Total No. of 
Embryos 
Cultured 
20 
20 
20 
20 
•significant at p < 0.05 from control Group I 
hsignificant at p ·< o. 05 from· Treatment Groups 
Total No. 
Advancing to 
4-cell Embryo 
. 4•,b 
11 
14 
16 
III and IV 
% of 2-cell Embryos 
Advancing after 8 
hours Culture 
20 
55 
70 
80 
u, 
u, 
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and 14 PIEs to progress, respectively. These values were 
not found to be significantly different from the control 
group. However, in comparisons .between the lµg and both 
the 0.5µg and 0.25µg 17-B-estradiol treatment groups, it 
was found that the lµg group was significantly (p<0.05) 
different from Groups III and IV. Thus, 17-B-estradiol 
has an apparent dose response action on the 2-cell PIE 
progression. 
When 2-cell PIEs were cultured in the presence of 
tamoxifen at· Jµg, 2µg, and lµg amounts. (Treatment Groups 
V, VI, and VII) all groups.dem9nstrated a 70% progression: 
after 8 hours of incubation,. as. shown in table 4. 
Culture of 2-cell PIEs in a medium containing Jµg of 
nafoxidine, Treatment Group VIII, exhibited a ·75% 
' ·, - ' 
progression rate. All concentrations of tamoxifen 
demonstrated no significance from either the control,·· 
Group I, or Group VIII, the nafoxidine-treated medium. 
Likewise, Treatment.Group VIII showed no significance 
from the control. 
Progesterone was used in Treatment Groups IX, X, and 
XI (Table 5)-at concentrations of lµg, 0.5µg, and 
- 0.25µg, respectively. A progression of 75% of the 2-cell 
PIEs in Group IX was exhibited.as well as 65% for Group X 
and 70% for Group XI. These values, however, were not 
significant from the ethanol-saline control nor between 
Table 4. Interaction of antiestrogenic compounds-on the progression of 2-cell 
mouse preimplantation embryos in vitro culture for 8 hours. 
v-
VI 
VII 
VIII 
I 
Concentration of 
Drug/Vehicle per ml 
Tamoxifen (Jµg) 
Tamoxifen (2µg) 
Tamoxifen ( lµg) 
Nafoxidine (Jµg) _ 
Ethanol-Saline 
Control (50µ1) 
Total No. of 
Embryos 
Cultured 
20 
20 
20 
20 
20 
Total No. 
Advancing to 
4-cell Embryo 
14 
14 
14 
15 
16 
% of 2-cell Embryos 
Advancing after 8 
ho'!lrs Culture 
· 70 
70 
70 
75 
80 
!JI 
-.J 
Table 5. Interaction of progesterone on the progression of 2-cell mouse 
preimplantation embryos in vitro culture for 8 hour's.· 
Group Concentration of 
Drug/Vehicle per ml 
IX Progesterone ( lµg) _ 
X Progesterone (0.5µg) 
XI ·Progesterone .(0.25µg) 
I Ethanol-Saline 
Control (50µ1) 
Total No. of 
Embryos 
Cultured 
20 
· 20 
20 
20 
Total No. 
Advancing to 
4-cell Embryo 
15 
13 
14 
16 
%_of 2~cell Embryos 
Advancing after 8 
hours Culture 
75 · 
65 
60" 
80_ 
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each of the progesterone treated groups. 
Besides tamoxifen, nafoxidine, and progesterone each 
being incubated in Whitten's Modified Medium alone, each 
was incubated in the medium along with a lµg allocation 
of 17-B-estradiol. The results are listed in table 6. 
When lµg of progesterone was incubated with·the 17-B-
estradiol (Group XVI) 45% of the 2-cell PIEs progressed 
to the 4-cell stage. This progression was not 
significant when compared tq the control group (Group II) 
which was incubated· ·in only lµg of 17-B-estradiol in -the 
medium. When compared to the control Group I, treatment 
with ethanol-saline alone, it was found that progesterone 
and 17-B-estradiol when combined significantly decreased 
cell viability (p<0.05). Therefore showing no 
significant protection by progesterone from estrogen at 
the 2-cell stage of development. 
The culture of Jµg nafoxidine with 17-B-estradiol 
(.Group XV) produced similar numbers as the progesterone, 
Treatment Group XVI (Table 6). Upon culture Of tamoxifen 
with 17-B-estradiol _in Groups XII, XII, al)d XIV it was 
found that both Jµg (XII) and 2µg (XIII) provided for 
35%, while tamoxifen at a ·1µg concentration 'in the 
presence of 17-B-estradiol (Group XIV) produced 40% PIE 
progres·sion (Table· 6). None of· these values were 
significant at the p<0.05 level when compared to the 
Table 6. Interaction of tamoxifen, progesterone·and nafoxidine while.in the 
presence .of a lµg concentration of 17-B-estradiol on the progression 
of 2-cell mouse preimplantation embryos in vitro culture for s hours.· 
Group· ·concentration of 
Drug/Vehicle per ml 
XII Tanioxifen (3µg) +: 
17-B-Estradiol (lµg) 
XIII Tamoxifen (2µg) + 
11,,,s-estradiol (lµg) 
XIV Tamoxifen (lµg) + 
17-8-estradiol (lµg) 
XV Na'foxidine (3µg) + 
17-B-estradiol- ( lµg) 
XVI· Progesterone ( lµg) + 
17.-B-estradiol ( lµg) 
I Ethanol-Saline· 
Control (50µ1) 
Total No. of 
Embryos 
cultured 
20 
20 
20 
20 
20 
20 
II 17-B-Estradiol 20 
Control (lµg) 
Total No. 
Advancing to 
-4-c!a!ll Embryo 
7• 
7• 
s• 
9• 
16 · 
•significant at p < o .. 05 from· Treatment Group I 
% of 2-cell Embryos 
Advancing after 8 
hours culture 
35 
35 
40 
45 
45 
80 
20 
gi 
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control, Group II, consisting of only 1µg of 17-B-
estradiol. No significant difference was noted between 
Treatment Groups XII, XIII, ·and XIV, or XVI. However, 
there was still a significant level of inhibition of PIE 
progression when compared to PIEs cultured in the· 
presence of ethanol~saline alone. 
When 2-cell PIEs were cultured in the presence of 
varying concentrations of a steroid synthesis blocker, 
aminoglutethimide, it was found that lOµg, 1µg, and 0.1µg 
concentrations (Groups XVIII, XIX, and XX) allowed for· 
75%, 70%, and 85% progression (Table·7). These values 
are not significant from the control group of methanol-
saline (Group XVII), which was predetermined to be a 
suitable medium for 2-cell PIE progression in-a similar 
manner as the control, Group I. Groups XVIII, XIX, and 
XX were also noted as not being significant from each 
other. 
Pour ce°il PIEs: Data obtained for 4-cell PIEs 
incubated for a hours in specific treatment groups are 
presented in tables 8 - 12. The.control, Treatment Group 
I (ethanol-saline solution), provided a 7.0% progression 
to the a-cell stage. This showed that the use of Group I 
as a control in 4-,cell PIE progression studies was 
possible due to its permissive action allowing for PIE 
progression. 
Table 7. Interaction of aminoglutethimide on the progression of 2-cell mouse 
preimplantation embryos in vitro culture for 8 hours. 
Group 
XVIII 
XIX 
xx 
XVII 
concentration of 
Drug/Vehicle per'ml 
Aminoglutethimide 
(l0µg) 
Aminoglutethimide 
(lµg) 
Aminoglutethimide 
(0.lµg) 
Methanol-Saline 
Control (50µ1) 
Total No. of 
Embryos 
Cultured 
20 
20 
20 
20 
Total No. 
Advancing to 
4-cell Embryo 
15 
14 
17 
16 
% of 2-cell Embryos 
Advancing after 8 
ho.urs Culture 
75 
70 
85 
80 
R3 
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Collected data for the influence of 17-B-estradiol 
at varying concentrations on 4-cell PIE progression are 
presented in table a. Treatment Group II. (lµg of 17-B-
estradiol) exhibited a progres~ion of 17 PIEs out of 20. 
This progression of 85%-to the a~cell stage was found not 
to be significant from the control, Group I. 
Concentrations of o. 5µg and o .• 25µg 17-B-estradiol both 
allowed 16 out of 20 PIEs to progress for an 80% 
viability that was .also not significant. 'No significance 
was visible between Groups II, III, and IV, the varying 
concentrations of 17-B-estradiol. 
When 4-cell PIEs were cultured in the presence of 
tamoxifen at 3µg; 2µg, and lµg amounts (Groups V, VI, and 
VII) :all showed signific13-nce (p<0.05) with_ 20%· (4 of 20), 
15% (3 of 20), and 15% (3 of 20) respectively (Table 9). 
Treatment Group xv (3µg of 'nafoxidirie) ·allowed only 4 of 
20 PIEs' to· develop -,for a 20% viability that was 
. . . ' 
significant (p<0.05) from the control. The four anti-
estrogenic treatment groups (Groups V, VI, VII, and VIII) 
showed no significance between each other. These results 
suggest that tamoxifen and na.foxidine are both inhibitory 
to 4-c.ell PIES. 
Treatment Groups IX, X, and XI ·(lµg, 0.05µg, and· 
0.25µg of progesterone) showed progressions of 14 of 
20(70%), 15 of.20 (75%), and 15 of 20 (75%) respectively 
Table 8. Interaction of 17-B-estradiol on the progression of·4-cell mouse 
preimplantation embryos in.vitro culture for 8 hours. 
Group 
II 
III 
IV 
I 
Concentration of 
Drug/Vehicle per ml 
17-6-Estradiol (lµg) 
17-B-Estradiol 
(0.5µg) 
17-B-Estradiol 
(0.25µg) 
Ethanol-Saline 
Control (50µ1) 
Total No. of. 
··'Embryos 
Cultured 
20 
20 
'. 
·20 
20 
Total No; 
Advancing to 
· a-cell Embryo 
17 
16 
16 
14 
· % of 4-cell Embryos 
Advancing after 8 
hours Culture 
85 
80 
80 
70 
Table 9. Interaction of antiestrogenic compounds on the progression of 4-cell 
mouse preimplantation embryos in vitro culture for 8 hours. 
Group Concentration of 
Drug/Vehicle per ml 
V Tamoxifen (Jµg) 
Vl Tamoxifen (2µg) 
VII Tamoxifen (lµg) 
VIII Nafoxidine (3µg) 
Total No. of 
Embryos 
Cultured 
20 
.20 
20 
20 
I Ethanol-Saline 20 
Control (50µ1) 
•significant at p < 0.05 from control Group I 
Total No. 
Advancing to 
a-cell Embryo 
3• 
3• 
4• 
14 
% of 4-cell Embryos 
Advancing after 8 
hours Culture 
20 
15 
15 
20 
70 
(Table 10). None of these groups was significant from 
either the control, Group I, or each other. 
When PIEs were cul tur.ed in the presence of lµg 
progesterone and lµg 17-B-estradiol (Group XVI) 75% 
advanced to the a-cell stage, which was not significant 
from the controls, Groups I and II (Table 11). Culture 
Groups XII, XIII, XIV, and XV all showed significant 
(p<0. 05) decr·eases in progression · compared to Group II., 
and there was a significant decrease in viability from 
the ethanol-saline control, Group I (Table 11).. There 
. . . 
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was no significance between Groups XII, XIII, XIV, and 
XV. These result substantiate that nafoxidine and 
tamoxifen act in an anti-estrogenic manner at the 4-cell 
stage. 
Four-Cell PIE progression was also noted not to be 
inhibited significantly by aminoglutethimide (Table 12) 
at concentrations of l0µg (Group XVIII), lµg· (Group XIX), 
and 0.lµg (Group-XX) when compared to the·control, Group 
XVII, of a methanol-saline solution. 
Eight Cell PIEs: Tables 13 - 17 contain information 
on the progression·of 8-ceil PIEs in the various 
treatment groups. Control Group I (ethanol-saline 
treatment) and control.Group XVII (methanol-saline) were 
determined to be suitable culture groups to allow for a-
Table 10. Interaction of progesterone on the progression of 4-cell mouse 
preimplantation embryos in vitro culture for 8 hours. 
Group 
IX 
X 
XI 
I 
Concentration of 
Drug/Vehicle per ml 
Progester·one ( lµg). 
Progesterone (0.5µg) 
Progesterone (0.25µg) 
Ethanol-Saline 
Control (50µ1) 
· Total No. of 
Embryos 
Cultured 
20 
20 
20 
20 
Total No. 
Advancing to 
8-ceil Embryo 
14 
15 
15 
14 
% of 4-cell Embryos 
Advancing after 8 
.hours Culture 
70 
75 
75 
70 
Table 11. Interaction of tamoxifen, progesterone and nafoxidine while in the 
presence of 17-8-estradiol on the progression of 4-cell mouse 
preimplantation embryos in vitro culture for 8 hours. 
Group Concentration of Total No. of Total No. % of 4-cell Embryos 
Drug/Vehicle per ml Embryos Advancing to Advancing after 8 
Cultured a-cell Embryo hours Culture 
XII Tamoxifen (Jµg) + 20. 5•,b 25 
17-B-Estradiol (lµg) 
XIII Tamoxifen (2µg) + 20 5•,b 25 
17-B-estradiol (lµg) 
XIV Tamoxifen (lµg) + 20 6*,b 30 
17-B-estradiol (1µg) 
xv Nafoxidine (Jµg) + 20 ga,b 40 
17-B-estradiol (1µg) 
XVI .Progesterone (1µg) + 20 15 75 
17-B-estradiol (1µg)_ 
I Ethanol-Saline 20 14 70 
Control (50µ1) 
II 17-B~Estradiol 20 17 85 
Control (1µg) 
•significant at p < 0.05 from control Group I 
bsignificant at p < o.o5 from control Group II 
0\ 
00 
Table 12. Interaction of .aminoglutethimide on the progression of 4-cell mouse 
preimplantation embryos in vitro culture for 8 hours. 
Group 
XVIII 
XIX 
xx 
XVII 
Concentration of 
Drug/Vehicle per ml 
Aminoglut~thimide 
(l0µg) 
Aminoglutethimide 
(lµg) 
Aminoglutethimide 
(0.lµg) 
Methanol-Saline 
Control (50µ1) 
Total No. of 
Embryos 
Cultured 
'20 
20 
20 
20 
:"'Total No.· 
: Advancing to 
a-cell Embryo 
15 
15 
17 
17 
% of 4-cell Embryos 
Advancing after 8 
hpurs Culture 
75 
75 
85 
85 
70 
cell PIE progression to the morula stage of development. 
Collected data for the influence of 17-B-estradiol 
at varying concentrations on a-cell PIE progression to 
the morula stage are presented in table 13. Treatment 
Group ,II (lµg of 17-B-estradiol) exhibited a progression 
of 16 PIEs out of _20. This progression of 80% to the 
morula stage was found not to be significant from the 
control, Groµp I. ,A concentratiqn of 0.5µg. (Group _III) 
allowed 16 out of. 20 PIEs to ·.progress· for _a so·% viability 
and a 0.25µg.concentration of 17-B-estradiol (Group IV) 
allowed 15 of 20 to progress for 75% viability. These 
two were not fo·und to be significant from the control. 
No significance was visible between Groups II, III, and 
IV, the varying concentrations of 17-B-estradiol. 
Treatment Groups V (Jµg tamoxifen), VI (2µg 
tamoxifen), VII (lµg tamoxifen), and VIII (3µg 
nafoxidine) .all showed a significant (p<O. 05) decrease in 
progression :to tp.e·morula stage when compared to the 
control (Group I), but no significance to ·each other . 
(Table 14). These declines from a progression rate of 
85% for the control (Group I). to 25% (Group V), 20% 
(Group VI), 25% Group VII), and 35% (Group VIII) 
demonstrate an inhibition by the anti-estrogenic 
compounds, and support the suggestion that tamoxifen and 
nafoxidine are potent inhibitors at the a-cell level of 
_Table 13. Ipteraction · of 17-B-estra.diol on the progression of a-cell mouse 
preimplantation embryos in vitro culture for .·s hours. 
Group concentration of 
Drug/Vehicle per ml 
II 17-B-Estradiol (1µg) 
III 17-B-Estradiol 
(0 .. 5µg) 
IV 17-B-Estradiol 
(0.25µg) 
I Ethanol-Saline 
Control (50µ1) 
Total No. of 
Embryos 
· Cultured 
20 
20 
20 
Total No. 
Advancing to 
morula stage 
16 
16 
15 
17 
% of a-cell Embryos· 
Advancing after 8 
hours Culture 
80 
80 
75 
85 
-.J 
.... 
Table 14. Interaction of antiestrogenic compounds on the progression of a-cell . 
mouse preimplantation embryos in.vitro culture for 8 hours. 
Group 
V 
VI 
VII 
VIII 
Concentration of 
Drug/Vehicle per ml 
Ta.moxifen (3µg) 
Tamoxifen (2µg) 
Tamoxifen (.lµg) 
Nafoxidine· (3µg) 
Total-No. of.·. 
· ;. Embryos · 
Cultured. 
-. 
20 
20 
"20 
20 
I Ethanol-Saline 20 
Control (50µ1) 
•significant at p < 0.05 from control.Group I 
Total No. 
Advancing to 
morula stage 
17 
% of a-cell Embryos 
Advancing after 8 
hours culture 
25 
20 
25 
35 
85 
73 
development. 
Incubation of PIEs in the presence of progesterone 
produced the data shown in table 15. Progesterone 
concentrations of lµg (Group IX), 0.5µg (Group X), and 
0.25µg (Group XI) allowed 75%, 80%, and 70%' of the a-cell 
PIEs to progress, respectively. All of these values· were 
determined not to be significant from the control, Group 
.I. Neither were they found to be significant from one 
another. 
Upon-incubation of 8-cell PIEs in the presence of 
17-B-estradioLand varying concentrat'ions.of tamoxifen 
(_3µg,- :2µg, and lµg) in Groups XII, XIII, and XIV, it was 
found that PIE progression is significantly (p<0.05) 
decreased compared to the .controls o{ Group I and II 
(Table 16) .: These values of 35.% · for Group XII, 30% for 
Group XIII, and 30% for Group XIV suggest that tamoxifen 
is a potent anti-estrogenic compound in the a-cell PIE. 
Culture of 3µg nafoxidine in the presence of 17-B-
estradiol (Treatment Group XV) also demonstrated a 
significant (p<0.05) decrease in PIE progression to 45% 
from 80% allowed by the presence of lµg 17-B-estradiol in 
Group II. This suggests nafoxidine also has anti-
estrogenic effects like tamoxifen. ·culture Group XVI 
(lµg progesterone and lµg of 17-B-estradiol) demonstrated 
no significant.difference in progression when compared to 
Table 15. Interaction of progesterone on the progression of 8-cell mouse 
preimplantation·embryos in vitro culture for 8 hours. 
Group Concentration of 
Drug/Vehi~le per ml 
IX Progesterone (lµg) 
X Progesterone (0.5µg) 
XI 
I 
Progesterone (0.25µg) 
Ethanol-Saline 
Control. (50µ1). 
Total No. of 
Embryos 
Cultured 
20 
20 
20 
Total No. 
Advancing to 
morula stage 
15. 
16 
14 
17 
% of 8-cell Embryos 
Advancing after 8 
hours Culture 
75 
80 
70 
85 
Table 16. Interaction of tamoxifen, progesterone and nafoxidine while in the 
presence of 17-B-estradiol on the progression of 8-cell mouse 
preimplantation embryos in vitro culture for 8 hours. 
Group Concentration of Total No. of Total No. % of 8-cell Embryos 
Drug/Vehicle per ml Embryos Advancing to Advancing after 8 
Cultured morula stage hours Culture 
XII Tamoxifen (Jµg) + 20 7•,b 35 
17-B-Estradiol (lµg-) 
XIII Tamoxifen (2µg) + 20 6a,b 30 
17-B-estradiol (lµg) 
XIV Tamoxifen (lµg) + 20 . 6a,b 30 
17-B-estradiol (;J .. µg). 
XV. Nafoxidine (3µg) + 20 ga,b 45 
17-B-estradiol (lµg) 
XVI Progesterone (lµg) + 20 15 75 
17-B-estradiol (lµg) 
I Ethanol-Saline 20 17 85 
control (50µ1) 
II 17-B-Estradiol 20 16 80 
control (lµg) 
•significant at p < 0.05 from control Group I 
hsignificant at p < o.05 from control Group II 
ul 
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the controls (Groups I and II), 
PIEs in Treatment Group XVIII, incubated in the 
presence of lOµg aminoglutethimide, showed that 30% of 
the PIEs had advanced to the morula stage. Treatment 
Group XIX (lµg aminoglutethimide) allowed 40% progression 
and Group XX (O.lµg aminoglutethimide) allowed 55% 
progression. These values were found to be significantly 
(p<0.05) decreased in comparison to the control group .of 
the methanol-saline solution (Group XVII). (Table 17). 
Therefore, the synthesis of endogenous steroids by the a-
cell PIEs is apparently important for proper development. 
The progression rate of PIEs in Treatment Group XVIII was 
also found to be significantly (p<0.05) less than Group 
XX but not Group XIX. These results suggest a dose 
responsive reaction of a-cell PIEs to aminoglutethimide. 
Receptor Determination Data 
Positive control slides of human breast cancer 
tissue known to stain positively using the ER-ICA and 
PgR-ICA systems were assayed; The resulting tissue 
proved to be p'ositively -~·t.ained (greater than 20% of the 
. nucl_ei were of a reddish-brown color) • The. negative 
control slide·, PIEs incubated, in the presence of normal 
rat IgG no~ specific for either estrogen-or progesterone· 
receptors, demonstrated no visible reddish".'brown 
Table 17. Interaction of aminoglutethimide on the progression of 8-cell mouse 
preimplantation.embryo~_in vitro culture. for 8 hours. 
Group 
XVIII 
XIX 
xx 
XVII 
Concentration of 
Drug/Vehicle per ml 
Aminoglutethimide 
(l0µg) 
Aininoglutethimide 
(lµg) 
Aminoglutethimide 
(0.lµg) 
Methanol-Saline 
control (50µ1) 
•significant at p < 0.05. from 
bsignificant at p < 0.05 fre>m 
Total No. of 
Embryos 
Cultured 
20 
20 
20 
20 
Total No. 
Advancing to 
moru·1a stage 
6a,b 
s• 
11' 
17 
control Group XVII 
T.reatment Group XX 
% of 8-cell Embryos 
Advancing after 8 
.hours Culture 
30 
40 
55 
85 
-.J 
-.J· 
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coloration of the nuclei or the embryonic cells 
themselves from any of the 2-cell, 4-cell, and 8-cell 
PIEs. · Therefore, confirming·no cross-reactivity between 
the rat IgG and mouse antigen • 
. The ER-ICA monoclonal assay technique performed on 
2-cell, 4-cell, and a-cell PIEs showed no visible 
reddish-brown colored nuclei,· and the nuclei were only 
st_ained _green, due to th~ counterstain. Therefore, the 
·estrogen receptors were not .found to be present in 
; ' -
detectable concentrations of 1x10-14M or greater • 
. The PgR-ICA monoclonal assay technique performed on 
2-cell, 4-cell, and a-cell PIES showed·no'visible 
reddish-brown colored nucle.i, and the nuclei were only 
stained green, due to the.counterstain. Therefore, the 
progesterone receptors were·not found to be present in 
detectable concentrations of 1x10-14M or greater. 
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CHAPTER IV 
DISCUSSION 
Steroidfl have been shown to influence RNA 
P.roduction, protein synthesis, and development of 
preimplantation embryos (Schultz, 1986; DeMoss, 1991). 
Preliminary studies ·by DeMoss (1991) have suggested that 
17-B-estradiol has no effect upon PIE protein profiles, 
but shows inhibition on cell viability at the.2-ce11· 
stage of development. The observations o( progesterone 
influences have been concentrated on the blastocyst stage 
and in a lesser amount upon a-cell PIE viability. Low 
concentrations of progesterone have not been found to 
inhibit a-cell PIE development (Warner and Tollefson, 
1978) and blastocyst progression (Whitten, 1965b and 
1957b; Kirkpatrick, 1971). The influence of .17-B-
estradiol and progesterone upon 2-cell, 4-cell, and a-
cell viability is reported in this research. 
Viability Considerations 
Viability studies showed Whitten's Modified Medium 
to be efficient for in vitro culture of 2-cell, 4-cell, 
and a-cell PIEs. During the 8 hour incubation period the 
.. 
control groups; containing ethanol and methanol treated 
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media, showed that PIE stages were successful in 
advancing to the next stage of development. This success 
was an important accomplishment, especially for the 2-
cell stage PIE development, to be assured of no block 
phenomenon as had been reported for some mouse strains 
(Whitten and Biggers, 1968). Because of the high 
progression rates in the control Treatment Groups I and 
XVII the ethanol and methanol respective influence upon 
development was considered to be insignificant as an 
experimental variable. 
Two Cell PIEs: Two cell PIEs treated with different 
co_ncentrations of estrogen _ produced varying numbers of 
progression rates. As shown in Table 3 Treatment Group 
II, containing lµg 17-B-estradiol, PIE advancement was 
signifi_cantly lower than the advancement for the control 
group, ·suggesting that 17-B-estradiol is not required for 
2-cell PIE advancement and appears to have an inhibitory 
effect, possibly through some· form of negative regulation 
of .g~n'omic · transcription dur.ing · the late :i-cell stage. 
This supports the findings of OeMoss (1991) that 17-B-
estradiol inhibited 2-cell progression. The variable 
progression rates, listed in table 3, demonstrate how'17-
. ' 
·s-estradiol influences 2-cell PIE development in a 
concentration dependent manner •. This, therefore·, 
suggests that 2-cell PIEs are inhibited according to 
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estrogen concentrations. 
Tamoxifen and nafoxidine treated 2-cell_ PIEs 
progressed to the 4-cell stage similar to Group I (Table 
4), demonstrating the lack of toxicity of these two 
antiestr.ogens at this level of development as earlier 
demonstrated by DeMoss (1991) .. Progesterone also 
demonstrated a lack of toxicity when compared to Group I 
(Table 5) and no inhibitory effects upon 2-cell PIE 
viability were observed. 
Tamoxifen and 17-B-estradiol treated 2-cell PIEs in 
Groups XII, XIII, and XIV did not significantly progress 
to the 4-cell stage when compared to PIEs in Group II 
·(Table 6). ,These data- suggests that' tamoxifen does not 
0 
' c ' • • L • 
provide protection from the toxicity of 17-B-estradiol at 
the _2-cell stage, · however, the treatment groups showed 
significantly less progression than the cc;mtrol Group I. 
Ther_e_ was no signif;icance notE!d between the ·effects of 
varying concentrations of tamoxifen on 2-cell PIE 
progression. The effec:ts of nafoxidine when cultured 
with 17-B-estradiol also demonstrated the same results as 
Groups XII, XIII; and XIV. This demonstrates the effects 
of nafoxidine appeared similar to that of tamoxifen. 
Treatment Group XVI, progesterone and 17-B-estradiol 
treated PIEs, were not. found to allow a significantly 
greater number of 2-cell PIEs to progress than the 
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estrogen only treatment of Group II (Table 6). This 
progression was found to be significantly less than 
control Group I, and suggested that progesterone did not 
provide significant protection_from the inhibitory effect 
of 17-.B-estradiol upon 2-cell PIE viability. 
Amirtoglutethimide treated Groups XVIII, XIX, and XX 
were found not to significa,ntly decrease 2-cell PIE 
progression' when compar.ed to control group XVII. 
Therefore, steroids, like e~trogen o~'progesterone, are 
apparently not being synthesized by the- 2-cell PIE and 
are not influencing 2.-cell PIE development. This 
' 
supports earlier findings that 2-cell PIEs do not 
synthesize steroids (Dickmann, et al., 1975). This 
further substantiates the theory that the molecules 
necessary for embryonic development through the 2-cell 
PIE are pre-packaged in the oocyte during maturation 
(liowlett and Bolton, 1985), 
Four Cell'PIEs: •Four cell PIES treated with 
estrogen produced no significant variation at any of the 
tested concentrations in progression rates when compared 
to the -control Group I (Table 8 l.. These data were unlike 
the 17-.B-estradiol treated 2-cell PIEs·which were 
significantly less than the control group. No · 
enhancement of progression was noted in the 4-cell PIEs, 
but the toxic effects of estrogen, demonstrated at the 2-
cell level, were not observed. This supports the 
conclusion of Warner and Tollefson (1977), that 
exogenously administered estrogen neither enhances nor 
inhibits embryo advancement. 
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Tamoxifen treated 4-cell PIEs were significantly 
inhibited in comparison to the control group at all· 
concentrations (Table.9). This inhibition, however, was 
not found to be concentration dependent at the levels 
tested. These data support DeMoss's (1991) suggestion 
that 4-cell PIEs are capable of endogenous estrogen 
production that is necessary for embr·yo development. 
This also suggests· there might be estrogen receptors 
within the 4-cell PIEs that.are necessary for the 
development of this embryonic stage and supports Howlett 
and Bolton's (1985) statement that the embryonic genome 
is active at the 4-cell stage. The negative influence of 
tamoxifen ~uggests a possible blockage of endogenously 
produced estrogen's influence upon 4-cell ·viability. 
Nafoxidine also demonstrated the same results as 
tamoxifen (Table 9), also demonstrating its 
antiestrogenic activity at the 4-cell stage. 
Progesterone-treated 4-cell PIEs demonstrated no 
significant inhibition or enhancement of viability (Table 
10) • 
Tam'oxifen.and 17_;8-estradiol treated 4-cell PIEs in. 
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Groups XII, XIII, XIV progressed to the a-cell stage in a 
significantly lower number in all cases when compared to 
PIEs in both Groups I and II (Table·11). These data 
suggests that tamoxifen inhibits 4-cell PIE development 
as earlier demonstrated by DeMoss's (1991) studies on 
viability and protein profil~s. There was no evidence of 
tamoxifen influences in a concentration dependent manner, 
supporting previous observations that tamoxifen inhibits 
estrogen stimulated growth in low concentratio~s (Fuller, 
1991). The effe_cts of nafoxidine when cultu:i:;ed with 17-
B-estradiol also demonstrated the same results at the 4-
·cell stage as Groups XII, XIII, XIV (Table 11). This 
demonstrates that the effect of nafoxidine is similar to 
that of tamoxifen. Treatment Group XVI, progesterone and 
17-B-estradiol treated PIEs, was found not to 
significantly inhibit nor enhance 4-cell PIE progression 
in comparison to Groups I and II (Table 11) .•. 
Aminoglutethimide trea~ed Gro~ps XVIII, XIX, and XX 
were not found not to significantly decrease 4-cell PIE 
" progression when compared to'control .Group XVII (Table 
12-).- This suggests no steroids are synthesized to 
con-t;rol 4-cell embryo develop111ent. These data, however, 
contradict the findings that tamoxifen and nafoxidine 
. 
inhibit 4-cell PIE development possibly by preventing 
endog~nously produced estrogen from binding its 
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respective receptor. The results possibly result from 
the production of small amounts of steroids sufficient 
for 4-cell·PIE development prior to the addition of 
aminoglutethimide. This suggestion of low endogenous 
steroid production is also supported by Kendall's (1979) 
findings that there are low concentrations of 3B-HSD, an 
enzyme.necessary for the biosynthesis of most steroids, 
at this stage of development·. 
Eight Cell PIEs: Eight cell PIEs treated with 
varying concentrations of estrogen produced no 
significant variation at any of the tested concentrations 
in viability when compared to the control, Group I {Table 
. . . . 
13). These 'ciata were unlike the 17-B-estradiol treated 
2-ce_ll PIEs, which were significantly decreased iri 
viability, and similar to the 4-cell PIE data. The lack 
·of the toxic effects of estrogen upon s~cell PIEs ~urther 
supports the understanding that exogenou·s·ly administered 
estrogen neither enhances nor inhibits embryo advancement 
{Warner and Tollefson, 1977); 
The treatment of a-cell PIEs with tamoxifen produced 
significant inhibition of PIE development: in comparison 
to the control group at all concentrations {Table 14). 
This inhibition, however, was not found to be 
concentration dependent at the levels tested. This 
supports the suggestion that a-cell PIEs are capable of 
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endogenous estrogen production which is necess·ary for 
embryo development (Demoss, 1991). These data also 
suggest that there might be estrogen receptors within the 
8-cell PIEs that are necessary for the development of 
this embryonic stage and support the statement that the 
embryonic genome is active at the 8-cell stage (Howlett 
and Botton, 1985). The negative influence of tamoxifen 
suggests a blockage of possible endogenously produced· 
estrogen. Nafoxidine also demonstrated the same results 
as tamoxifen (Table 14), therefore, demonstrating that 
' . ' ~ . . . . 
its antiestrogenic activity is similar to tamoxifen•s at 
the 8-cell stage. Progesterone treated 8-cell PIEs 
demonstrated no significant inhibition or enhancement of 
viability (Table 15). 
Treatment of 8-cell PIEs·in Groups XII, XIII, XIV 
with tamoxifen and 17-B-estradiol together caused the 
progression to _the morula stage to be signiticantly lower 
in all cases when compared to both controls, Groups I and· 
II (Table 16). This suggests tamoxifen inhibition of 8-
cell PIE development as earlier demonstrated by DeMoss 
(1991). The effects of nafoxidine when cultured with 17-
·s-estradiol also demonstrated the same results at the 8- • 
cell stage as Groups XII, XIII, XIV (Table.16) as earlier 
demonstrated by Roy, et al. (19.81). These results 
suggest that both nafoxidine and tamoxifen have 
inhibitory effects at the 8-cell stage. 
Progesterone and 17-B-estradiol treated PIEs, 
Treatment Group XVI, demonstrated no significant 
inhibition or enhancement of 8~cell PIE viability in 
comparison to Groups I and II (Table 16). 
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Aminoglutethimide treated Groups XVIII, XIX, and xx 
were found to be significantly inhibited in comparison to 
the control, Group XVII (Table 17). These data suggest 
that the synthesis of endogenous steroids·by the a-cell 
PIEs is required for continued development to the morula 
stage and supports the theory that the embryonic genome 
is_e~pressed in a-cell PIEs (Howlett and Bolton, 1985). 
This also suggests the importance of endogenous steroids 
upon early embryogenesis especially during the_ 8-cell 
stage of development, and endogenous steroid production 
occurs within a-cell PIEs as has been foun~ in 16-cell 
PIEs (Dickmann, et al., 1985). 
Receptor Considerations 
The positive control slides for both ER~ICA and PgR-
ICA demonstrated the procedure was working properly. The 
·negative control also demonstrated the- lack of cross-
reactivity by the rat IgG with mi::,use 2-cell, 4-cell, ·or 
8 ..... cerl .PIEs. The' ER-ICA and PgR-ICA monoclonal assays 
. ' . . ' . 
failed to demonstrate the presence of _either estrogen 
receptors or progesterone receptors at greater than or 
equal to 1x10-14M concentrations. However, these results 
may be inconclusive due to the zona peilucida being 
present, which may act as a barrier preventing the 
entrance of the antibodies and reagents into the 
embryonic cells and preventing staining. It is ~lso 
possible these receptors are present in lower 
concentrations, but to date no evidence has been 
presented to support this. 
Summary 
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Treatment of 2-cell PIEs with 1µg 17-S-estradiol 
produced significantly lowe~ rates of progression than 
both the ethanol-saline control and tamoxifen treated 
groups. In 4-cell and a-cell cultured PIEs, the control 
and 17-B-estradiol treated groups yielded significantly 
higher percentages of viable PIEs thari the tamoxifen 
tre'ated group •... This supports. the concept that 
embryo_genic genome initiation .begins at the late 2-cell 
. ' ·/. ' ' . 
PIE stage (Schultz, 1986). 
·The inhibitory action of·11-s-e~tra~iol on 2-cell 
' , 
PIEs demonstrates the second cleavage division to the-4-
cell stage is not estrogen dependent. A decline in 
cleavage inhibition was not_ed wi.th the decline of 17-B-
estradiol concentration. This suggests the inhibition of 
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17-8-estradiol is concentration dependent. 
Viability studies in tamoxifen and nafoxidine 
supplemented groups of 2-cell, 4~ceil, and 8-cell PIEs 
demonstrated no significant effects upon 2-cell viability 
.and sign_ificant inhibition at the 4-cell and 8-cell 
stages. This supports the non-steroidal antiestrogenic 
properties of tamoxifen reported by DeMoss (1991) and 
nafoxidine (Roy, et al., 1981; Sengupta, 1982). The 
results also Sll,ggest the importance of the estrogen 
receptor and its presence within the 4-cell and 8-cell 
PIEs. Further, the reduction in viability demonstrates 
the suggested.production of endogenous estrogen by PIEs 
(Dickmann, et al., 1976). 
· Culture tests of 2-cell· .PIEs in the presence of an 
anti~strogen plus 17-B-estradiol were found to 
· significantly inhibit. PIE progres·sion. . PIEs, 4-cell and 
a-cell, cultured in the presence of the antiestrogen plus 
17-8-estradiol were fol.ind to be significantly inhibited 
in comparison to the ethanol-saline control and the PIEs 
cultured iri the presence of only 17-B-estradiol. This 
further demonstrated that the antiestrogenic activity of 
tamoxifen and nafoxidine are similar in early PIE 
devE;llopment·. Also, the data suggest a possible 
dependence of 4-cell and 8-cell PIEs upon estrogen 
activation of the embryonic genome through an estrogen 
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receptor since both nafoxidine and tamoxifen employ their 
antiestrogenic activity by binding the estrogen receptor 
specifically (Fuller, 1991) • Estrogen receptor studies., 
however, did not indicate the presence of the receptor at 
concentrations of 10 fmoles/mg of protein or higher, but 
the results did not rule out t:he possibility of receptor 
presence in lower.concentrations.· ~other possibility is 
the aritibodies were·not delivered inti:> the cells because 
of the zona pellucida acting as a barrier •. 
Treatment with progesterone at the 2-cell, 4-cell, 
. ' . 
and a-cell PIE stages demonstrat·ed no significant 
inhibition upon development at any stage. Progesterone 
treatment in conjunction with 17-B-estradiol treatment 
demonstrated no significant protection from the 
inhibitory effects of 17-B-estradiol at the 2-cell, 4-
cell, and 8-cell stages of development.· This suggests 
there is no-obvious.synergistic effect of progesterone 
and estradiol and supports Warner and Tollefson's (1978.) 
findings.that there is no effect of progesterone·and. 
estrogen together upon RNA synthesis in PIEs. 
Progesterone receptor determination studies revealed 
progesterone receptors are not present in concentrations 
greater than 10 fmoles within any of the 3 stages 
studied. However, these·results may have been 
inconclusive due to the possibility of the zona pellucida 
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acting as a barrier to the antibodies utilized. 
Treatment with _a steroid synthesis blocker, 
aminoglutethimide, demonstrated no significant inhibition 
of PIE progression at either the 2-cell or 4-cell stage 
of development. This suggests steroid synthesis at the 
2-cell and 4-cell stage as initially stated by Dickmann, 
et al. (1975) is not occurring. Steroid synthesis :inay 
not be necessary for 2-cell and 4-cell PIE progression, 
cir is only needed in small amounts that this experiment· 
failed to eliminate. The a-cell PIEs were significantly 
inhibited by the termination of steroid synthesis. 
Suggesting endogenous steroid production by a-cell PIEs 
as was found in 16-cell PIEs·(Dickmann, et al., 1985). 
These results suggest steroid synthesis at the a-cell 
stage is crucial for development. Aminoglutethimide was 
also shown to act in a concentration dependent manner 
upon a-cell PIE viability. 
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CHAPTER V 
CONCLUSIONS 
Data generated through viability studies suggest 
that exogenously administered 17-S-estradiol influences 
2-cell, 4-cell, and a-cell preimplantation embryo 
development. Administration of 17-S-estradiol was 
inhibitory to 2-cell PIEs but among 4-cell and a-cell 
cultured PI_Es,. 17-S-estradiol · influences were equal to 
the control treatments. Treatment of 4-cell and a-cell 
PIEs with supplements of both 17-S-estradiol and an 
antiestrogen demonstrate PIE dependence upon estrogen for 
development. Thus, the null hypothesis that.17-S-
estradiol influences PIE development is accepted. 
However, 2-cell, 4-cell, and a-cell PIE 
immu~ocytochemical studies. failed'to demonstrate estrogen 
receptors to be pres·ent in greater than 10 fmoles/mg of 
prot·ein. Therefore, the hypothesis, that estrogen 
receptors are present within PIEs is rejected. However, 
these results were inconclusive due to the unknown 
·influence of the zona pellucida upon the passage of 
immunoglobins into the embryonic cells. 
Progesterone viability studies show that it has no 
obvious influence over PIE development. 
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Immunocytochemical studies did not demonstrate 
progesterone receptors to be present at greater than 10 
fmoles/mg of protein. Therefore, the riul-1 hypothesis 
that progesterone influences PIE development is rejected, 
and the hypothesis that·progesterone receptors are 
present within PI Es was rejected. However, these re·sul ts 
were inconclusive due to the unknown influence of the 
zona pellucida upon the passage of immunoglobins into the 
embryonic cells. 
Tamoxifen arid nafoxidine treated 2-cell PIEs both 
produced results similar to the experimental control. 
Both were toxic to 4-cell and 8-cell PIEs. When 4-cell 
. . 
arid. a-cell PIEs were cultured in either tamoxifen or 
riafoxidine and i7-B-estradiol progression was still 
inhibited, These data demonstrate the antiestrogenic 
properties of tamoxifen and nafoxidine on· 4-cell and 8-
cell PIEs. Therefore, the hypothesis ·that tamoxifen and 
nafoxidine both have antiestrogenic properties in mouse 
PIEs is accepted. 
Aminoglutethimide treated 2-cell and 4-cell PIEs 
produced results similar to the experimental control, 
·suggesting the lack of endogenous steroid influence on 2-
cell and 4-cell PIEs. Treatment of ·a-cell PIEs with AG 
indicated endogenous steroi_d dep_endence for development. 
Therefore, the._ hypothesis that there is no endogenous 
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steroid synthesis by the preimplantation embryos that 
influence development is rejected for the a-cell PIE and 
accepted for the 2-cell and 4-cell PIEs. 
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